Processing 00000000.tx.1: Deletions of chromosome 5q13.3 and 17p loci cooperate in myeloid neoplasms Patricia D. 

Phrase: "Deletions of chromosome 5q13.3"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   851   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "17p loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "cooperate in myeloid neoplasms Patricia D."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   773   C2939461:Myeloid neoplasm [Neoplastic Process]
   753   C0027651:NEOPLASMS, NOS [Neoplastic Process]
   753   C0439677:Myeloid [Qualitative Concept]
   753   C1646907:Patricia [Eukaryote]
   719 E C2981607:NEOPLASM [Intellectual Product]
Processing 00000000.tx.2: Castro, Jan C. 

Phrase: "Castro,"

Phrase: "Jan C."
Processing 00000000.tx.3: Liang, and Lalitha Nagarajan From the Department of Molecular Genetics, Division of Pathology and Laboratory Medicine, University of Texas M.D.

Phrase: "Liang,"

Phrase: "and"

Phrase: "Lalitha Nagarajan From the Department of Molecular Genetics,"

Phrase: "Division of Pathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Laboratory Medicine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013227:Medicine, NOS [Pharmacologic Substance]
   861   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "University of Texas M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C1512018:M.D. [Intellectual Product]
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.4: Anderson Cancer Center, Houston, TX.  

Phrase: "Anderson Cancer Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Houston,"

Phrase: "TX."
Processing 00000000.tx.5: Abstract Top Abstract Introduction Materials and methods Results Discussion References Nonrandom interstitial deletions and monosomy of chromosomes 5,7,and 17in refractory myelodysplasia (MDS) and acute myelogenous leukemia (AML) suggest a multistep pathway that culminates in aggressive clinical course. 

Phrase: "Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Nonrandom interstitial deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1880274:Deletions [Activity]
   793 E C1442161:Deletion [Cell or Molecular Dysfunction]
   793 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "monosomy of chromosomes 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1513481:Monosomy 5 [Cell or Molecular Dysfunction]
   770   C0026499:Monosomy [Congenital Abnormality]

Phrase: "7,"

Phrase: "and"

Phrase: "17in refractory myelodysplasia (MDS)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0026985:Myelodysplasia [Congenital Abnormality]
   827   C0026986:Myelodysplasia [Neoplastic Process]
   827   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "and"

Phrase: "acute myelogenous leukemia (AML)"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a multistep pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "that"

Phrase: "culminates in aggressive clinical course."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1332223:Aggressive Clinical Course [Finding]
   806   C0449259:Clinical course [Temporal Concept]
   797   C0580822:Aggressive course [Temporal Concept]
           Aggressive
   760   C0001807:aggressive [Mental or Behavioral Dysfunction]
   760   C0205210:Clinical [Qualitative Concept]
   760   C0750729:Course [Temporal Concept]
Processing 00000000.tx.6: Because cytogenetic studies frequently identify chromosome 5and 17deletions within a single clone, we searched for allele loss for 5q loci and TP53 gene mutations in the same leukemic samples. 

Phrase: "Because"

Phrase: "cytogenetic studies frequently"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0200896:Cytogenetic Studies [Laboratory Procedure]
   827   C0010802:Cytogenetic [Biomedical Occupation or Discipline]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "identify"

Phrase: "chromosome 5and 17deletions within a single clone,"

Phrase: "we"

Phrase: "searched for allele loss"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   791   C0524869:Allelic Loss [Genetic Function]
   770   C0002085:Allele [Gene or Genome]
   770   C1517945:Loss [Quantitative Concept]
   770   C1706202:Searched [Activity]
   737 E C1552603:search [Intellectual Product]

Phrase: "for 5q loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "TP53 gene mutations in the same leukemic samples."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0079419:TP53 gene [Gene or Genome]
   770   C0596611:gene mutations [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0026882:Mutations [Genetic Function]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.7: Cosegregating deletions of chromosomes 5and 17were found to specifically include the 5q13.3 interval between the loci D5S672 and D5S620/D5S626, a locus hypothesized to harbor a tumor suppressor gene1 and the TP53 gene on 17p. 

Phrase: "Cosegregating deletions of chromosomes 5and 17were"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   811   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   753   C1880274:Deletions [Activity]
   719 E C1442161:Deletion [Cell or Molecular Dysfunction]
   719 E C1511760:Deletion [Genetic Function]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the 5q13.3 interval between the loci D5S672"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1272706:Interval [Temporal Concept]
   744   C1552654:Interval [Idea or Concept]
   744   C1552713:Interval [Intellectual Product]

Phrase: "and"

Phrase: "D5S620/D5S626,"

Phrase: "a locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708726:Locus [Gene or Genome]

Phrase: "hypothesized"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "harbor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0475311:Harbor [Manufactured Object]

Phrase: "a tumor suppressor gene1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0079427:Tumor Suppressor [Gene or Genome]
   734   C1325410:tumor suppressor [Cell Function]

Phrase: "and"

Phrase: "the TP53 gene on 17p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0079419:TP53 gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.8: A rare patient with secondary refractory MDS and an unbalanced translocation [der(5;17)], which resulted in deletions of the 5q13.3-qter and 17p loci, provided clues on the sequence of genetic alterations. 

Phrase: "A rare patient with secondary refractory MDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "an unbalanced translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519758:Unbalanced Translocation [Cell or Molecular Dysfunction]
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "[der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "],"

Phrase: "which"

Phrase: "resulted in deletions of the 5q13.3-qter"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C1521473:5q13 [Cell Component]
   744   C1880274:Deletions [Activity]
   711   C1274040:Result [Functional Concept]
   711 E C1442161:Deletion [Cell or Molecular Dysfunction]
   711 E C1511760:Deletion [Genetic Function]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "and"

Phrase: "17p loci,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "provided clues on the sequence of genetic alterations."
Processing 00000000.tx.9: Serial molecular analysis of this patient revealed a dysplastic clone with der(5;17), which gave rise to a leukemic clone on acquiring an inactivating mutation of TP53. 

Phrase: "Serial molecular analysis of this patient"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a dysplastic clone with der(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0009013:Clone [Cell]
   753   C1522642:Clone [Tissue]

Phrase: ";17"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "rise to a leukemic clone"

Phrase: "on acquiring"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0439661:acquiring [Temporal Concept]
   966 E C1706701:Acquire [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "an inactivating mutation of TP53."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.10: Our findings are consistent with functional cooperation between a putative tumor suppressor gene at 5q13.3 that contributes toward the progression of early stages of MDS, and the TP53 gene when mutated, causes transformation to AML. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are"

Phrase: "consistent with functional cooperation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "between a putative tumor suppressor gene"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0079427:Tumor suppressor gene [Gene or Genome]
           Tumor Suppressor
   861   C0017372:Suppressor gene [Gene or Genome]
   861   C1325410:tumor suppressor [Cell Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C1710252:Suppressor [Manufactured Object]
   812   C2954564:Suppressor [Pharmacologic Substance]
   812   C3273930:Tumor [Finding]

Phrase: "at 5q13.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521473:5q13 [Cell Component]

Phrase: "that"

Phrase: "contributes toward the progression of early stages of MDS,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C2363430:early stages [Temporal Concept]
   748 E C1517886:Early Stage [Classification]
   742   C0026985:Myelodysplasia [Congenital Abnormality]
   742   C0026986:Myelodysplasia [Neoplastic Process]
   742   C0033027:myelodysplasia [Neoplastic Process]
   742   C0242656:progression [Pathologic Function]
   742   C0449258:Progression [Functional Concept]
   742   C1279919:Early [Temporal Concept]
   742   C1306673:Stages [Qualitative Concept]
   742   C1880177:Contribute [Activity]
   708 E C0205390:Stage [Temporal Concept]
   708 E C1300072:Stage [Clinical Attribute]

Phrase: "and"

Phrase: "the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "when"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "transformation to AML."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0040682:Transformation [Cell Function]
   760   C1510411:Transformation [Pathologic Function]
   760   C1705163:Transformation [Research Activity]
Processing 00000000.tx.11: (Blood. 

Phrase: "(Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.12: 2000;95:2138-2143)  2000 by The American Society of Hematology.  

Phrase: "2000"

Phrase: ";95"

Phrase: ":"

Phrase: "2138-2143"

Phrase: ")"

Phrase: "2000 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.13: Introduction Top Abstract Introduction Materials and methods Results Discussion References The significance of cytogenetic alterations in predicting therapeutic outcome was recognized more than a decade ago.2,3 In refractory anemia with excess blasts (MDS-RAEB), refractory anemia with excess blasts in transformation (MDS-RAEB-t), and acute myelogenous leukemia (AML), nonrandom interstitial deletions 5q,7q or monosomy of 5and 7are markers for poor prognosis and short remission periods. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The significance of cytogenetic alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "in predicting therapeutic outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1274040:Outcome [Functional Concept]

Phrase: "was"

Phrase: "recognized"

Phrase: "more than a decade ago.2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205172:More [Functional Concept]
   753   C2981279:Decade [Quantitative Concept]

Phrase: "3 In refractory anemia"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0002893:Anemia, Refractory [Disease or Syndrome]
   833   C2981142:Refractory anaemia [Disease or Syndrome]
   770   C0002871:Anaemia [Disease or Syndrome]
   770   C0205269:Refractory [Functional Concept]
   770   C0439086:<3 [Quantitative Concept]
   770   C1000483:Anemia [Plant]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]

Phrase: "with excess blasts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337026:blasts [Natural Phenomenon or Process]
   861   C0368761:Blasts [Cell]
   861   C0523113:Blasts [Laboratory Procedure]

Phrase: "(MDS-RAEB"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002894:RAEB [Neoplastic Process]

Phrase: ")"

Phrase: ","

Phrase: "refractory anemia with excess blasts"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0002894:Refractory anaemia with excess blasts [Neoplastic Process]
   806   C0002893:Anemia, Refractory [Disease or Syndrome]
   806   C2981142:Refractory anaemia [Disease or Syndrome]
   760   C0002871:Anaemia [Disease or Syndrome]
   760   C0205269:Refractory [Functional Concept]
   760   C1000483:Anemia [Plant]

Phrase: "in transformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040682:Transformation [Cell Function]
  1000   C1510411:Transformation [Pathologic Function]
  1000   C1705163:Transformation [Research Activity]

Phrase: "(MDS-RAEB-t"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0280028:RAEB-T [Disease or Syndrome]
   827   C0002894:RAEB [Neoplastic Process]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "acute myelogenous leukemia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "(AML"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "nonrandom interstitial deletions 5q,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0796347:5q [Nucleotide Sequence]
   812   C1521461:5q- [Cell or Molecular Dysfunction]

Phrase: "7q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796361:7q [Nucleotide Sequence]

Phrase: "or"

Phrase: "monosomy of 5and 7are markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026499:Monosomy [Congenital Abnormality]

Phrase: "for poor prognosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0278252:Poor prognosis [Finding]
   861   C0033325:Prognosis [Health Care Activity]

Phrase: "and"

Phrase: "short remission periods."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C0425946:Short periods [Finding]
   793   C0439531:/period [Temporal Concept]
   793   C1948053:Period [Temporal Concept]
   743 E C0332182:Periodic [Temporal Concept]
   743 E C1706381:PERIODIC [Intellectual Product]
   721 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.14: Similarly, mutations of the tumor suppressor gene, TP53, are associated with resistence to therapy and poor prognosis in hematologic malignancies.4 This is in stark contrast to simple reciprocal translocations such as inv(16) in AML, for which the outcome is more favorable. 

Phrase: "Similarly,"

Phrase: "mutations of the tumor suppressor gene,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   783   C0038859:Suppressor Mutations [Cell or Molecular Dysfunction]
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "TP53,"

Phrase: "are"

Phrase: "associated with resistence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "to therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "and"

Phrase: "poor prognosis in hematologic malignancies.4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0278252:Poor prognosis [Finding]
   753   C0033325:Prognosis [Health Care Activity]

Phrase: "This"

Phrase: "is in stark contrast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1979874:Contrast [Qualitative Concept]

Phrase: "to simple reciprocal translocations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   867   C0333714:Reciprocal translocation [Cell or Molecular Dysfunction]
   827   C0040715:Translocations [Cell or Molecular Dysfunction]
   827   C1882911:Reciprocal [Qualitative Concept]
   793 E C2987521:Translocation [Activity]

Phrase: "such as inv(16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021943:inv [Cell or Molecular Dysfunction]
   861   C1425144:INV [Gene or Genome]

Phrase: ")"

Phrase: "in AML,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "for which"

Phrase: "the outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1274040:Outcome [Functional Concept]

Phrase: "is"

Phrase: "more favorable."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C3640814:Favorable [Qualitative Concept]
   789 E C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.15: Typically, RAEB, RAEB-t, and AML patients with deletions or monosomy of either 5q, 7q, or 17p have numerous additional karyotypic changes, the significance of which has not been extensively investigated. 

Phrase: "Typically,"

Phrase: "RAEB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002894:RAEB [Neoplastic Process]

Phrase: "RAEB-t,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0280028:RAEB-T [Disease or Syndrome]
   861   C0002894:RAEB [Neoplastic Process]

Phrase: "and"

Phrase: "AML patients with deletions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "or"

Phrase: "monosomy of either 5q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026499:Monosomy [Congenital Abnormality]

Phrase: "7q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796361:7q [Nucleotide Sequence]

Phrase: "or"

Phrase: "17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "have"

Phrase: "numerous additional karyotypic changes,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "the significance of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "extensively"

Phrase: "investigated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]
Processing 00000000.tx.16: Preferential combination of 1or more abnormalities may provide clues on the genetic alterations leading to the progression of AML. 

Phrase: "Preferential combination of 1or more abnormalities"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205195:Combination [Qualitative Concept]
   753   C1947911:Combination [Physical Object]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "clues on the genetic alterations"

Phrase: "leading to the progression of AML."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   800   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   770   C0023470:Myelogenous Leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205178:acute [Temporal Concept]
   744   C0242656:progression [Pathologic Function]
   744   C0332152:Leading [Temporal Concept]
   744   C0439677:Myelogenous [Qualitative Concept]
   744   C0449258:Progression [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.17: Deletions of 5q result in loss of large segments of the chromosome, which translates into physical loss of approximately 2% of the haploid genome. 

Phrase: "Deletions of 5q result"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "in loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of large segments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441635:Segment [Spatial Concept]
   777 E C0205122:Segmental [Spatial Concept]

Phrase: "of the chromosome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]

Phrase: "which"

Phrase: "translates into physical loss of approximately 2% of the haploid genome."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   738   C0017428:Genome [Gene or Genome]
   738   C0018590:Haploid [Quantitative Concept]
   738   C0031809:Physical [Health Care Activity]
   738   C0040710:translate [Occupational Activity]
   738   C0205485:Physical [Functional Concept]
   738   C0332232:Approximately [Qualitative Concept]
   738   C1509143:Physical [Finding]
   738   C1517945:Loss [Quantitative Concept]
   738   C2338314:Genome [Conceptual Entity]
Processing 00000000.tx.18: In a previous report, we identified a patient with de novo AML, who harbored a deletion at 5q13, and allowed the characterization of a critical locus between proximal markers, AFMb347yf9/D5S672, and distal markers D5S620/D5S626.1 The importance of this interval was further confirmed in an AML cell line, ML3, in which the entire chromosome 5q sequences are grossly intact, except at 5q13.3 and qter. 

Phrase: "In a previous report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a patient with de novo AML,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:*^patient [Patient or Disabled Group]

Phrase: "who"

Phrase: "harbored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "a deletion at 5q13,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the characterization of a critical locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "between proximal markers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "AFMb347yf9/D5S672,"

Phrase: "and"

Phrase: "distal markers D5S620/D5S626.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0205108:Distal [Spatial Concept]
   771   C0005516:Marker [Clinical Attribute]

Phrase: "The importance of this interval"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed in an AML cell line,"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   800   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   770   C0007600:Cell Line [Cell]
   770   C0023470:Myelogenous Leukemia [Neoplastic Process]
   767   C0085669:Acute leukaemia [Neoplastic Process]
   767   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   744   C0007634:Cell [Cell]
   744   C0023418:Leukaemia [Neoplastic Process]
   744   C0205132:Line [Spatial Concept]
   744   C0205178:acute [Temporal Concept]
   744   C0439677:Myelogenous [Qualitative Concept]
   744   C0521093:confirmed [Qualitative Concept]
   744   C0750484:Confirmed [Idea or Concept]
   744   C1269647:Cell [Cell]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   735   C1517806:Leukemic Cell [Cell]
   711 E C1456348:Confirm [Qualitative Concept]

Phrase: "ML3,"

Phrase: "in which"

Phrase: "the entire chromosome 5q sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "grossly intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205266:Intact [Qualitative Concept]
   861   C1554187:Intact [Idea or Concept]

Phrase: "except"

Phrase: "at 5q13.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521473:5q13 [Cell Component]

Phrase: "and"

Phrase: "qter."
Processing 00000000.tx.19: Subsequently, several studies on solid tumors support a critical locus at 5q13, which undergoes loss of heterozygosity (LOH) or allelic imbalance. 

Phrase: "Subsequently,"

Phrase: "several studies on solid tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a critical locus at 5q13,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1708726:Locus [Gene or Genome]

Phrase: "which"

Phrase: "undergoes"

Phrase: "loss of heterozygosity (LOH)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   790   C1517945:Loss [Quantitative Concept]

Phrase: "or"

Phrase: "allelic imbalance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887935:Allelic Imbalance [Cell or Molecular Dysfunction]
   861   C1397014:Imbalance [Sign or Symptom]
Processing 00000000.tx.20: These include malignancies of the lung,5 prostate,6 ovary,7 stomach,8 pancreas,9 and bladder.10 More importantly, in each of these studies, LOH of 5q13 loci is evident but not 5q23 (APC locus) or 5q31.1 (AML/MDS locus), indicating a distinct tumor suppressor locus at chromosome 5q13.3. 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "malignancies of the lung,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   819   C0242379:lung malignancies [Neoplastic Process]
   770   C0006826:MALIGNANCIES [Neoplastic Process]
   737 E C1306459:Malignancy [Finding]

Phrase: "5 prostate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033572:Prostate [Body Part, Organ, or Organ Component]
   861   C1278980:Prostate [Body Part, Organ, or Organ Component]

Phrase: "6 ovary,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0029939:Ovary [Body Part, Organ, or Organ Component]
   861   C0227898:ovary [Body Part, Organ, or Organ Component]
   861   C1278992:Ovary [Body Part, Organ, or Organ Component]

Phrase: "7 stomach,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0038351:Stomach [Body Part, Organ, or Organ Component]
   861   C1278920:Stomach [Body Part, Organ, or Organ Component]
   861   C1517454:STOMACH [Tissue]
   805 E C1704242:Gastric [Qualitative Concept]

Phrase: "8 pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "9"

Phrase: "and"

Phrase: "bladder.10 More importantly,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0005682:Bladder [Body Part, Organ, or Organ Component]
   812   C1281573:Bladder [Body Part, Organ, or Organ Component]
   812   C1511200:Bladder [Tissue]
   756 E C0205058:Vesical [Spatial Concept]

Phrase: "in each"

Phrase: "of these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "LOH of 5q13 loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   753   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]

Phrase: "but"

Phrase: "not 5q23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521480:5q23 [Cell Component]

Phrase: "(APC locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "5q31.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521487:5q31.1 [Cell Component]
   861   C0796362:5q31 [Cell Component]

Phrase: "(AML/MDS locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1708726:Locus [Gene or Genome]
   717   C0023467:Acute myelogenous leukaemia [Neoplastic Process]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "a distinct tumor suppressor locus at chromosome 5q13.3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.21: The deletions of 5q13 in ovarian cancer are particularly striking in that the 5q13 deletions correlate with mutations of the TP53 gene in 78% of tumors.7 In AML and MDS, mutations of the TP53 gene are infrequent, less than 10%. 

Phrase: "The deletions of 5q13"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "in ovarian cancer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "are"

Phrase: "particularly"

Phrase: "striking in"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0038452:striking [Occupational Activity]

Phrase: "that"

Phrase: "the 5q13 deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "correlate with mutations of the TP53 gene"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0079419:TP53 gene [Gene or Genome]
   774   C0596611:gene mutations [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in 78%"

Phrase: "of tumors.7"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "In AML"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "and"

Phrase: "MDS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "mutations of the TP53 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "infrequent, less than 10%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521114:Infrequent [Temporal Concept]
Processing 00000000.tx.22: However, in a subset of patients with "17p- syndrome," the TP53 gene is frequently mutated.11 A recent report on this distinct clinical entity demonstrated loss of the TP53 gene by 17p deletion in 14of the 16cases analyzed by fluorescent in situ hybridization (FISH). 

Phrase: "However,"

Phrase: "in a subset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515021:Subset [Classification]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with ""17p- syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: """"

Phrase: "the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "mutated.11"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1705285:Mutated [Cell or Molecular Dysfunction]
   827 E C1513776:Mutate [Genetic Function]

Phrase: "A recent report on this distinct clinical entity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1299495:Clinical report [Intellectual Product]
   744   C0684224:Report [Intellectual Product]
   744   C0700287:Report [Health Care Activity]
   744   C3273238:Report [Intellectual Product]

Phrase: "demonstrated"

Phrase: "loss of the TP53 gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "by 17p deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "in 14of"

Phrase: "the 16cases"

Phrase: "analyzed by fluorescent in situ hybridization (FISH)."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   882   C0162789:Fluorescent in Situ Hybridization [Molecular Biology Research Technique]
           fluorescent hybridization situ
   833   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   790   C0444498:In situ [Spatial Concept]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0936012:Analyzed [Research Activity]
   753   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.23: Enhanced expression or mutation of the remaining allele was observed in 11of 14cases.12 Interestingly, 15of 17patients in this study also had karyotypic deletions of chromosome 5.

Phrase: "Enhanced expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "mutation of the remaining allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed in 11of 14cases.12 Interestingly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1441672:Observed [Functional Concept]

Phrase: "15of 17patients in this study also"

Phrase: "had"

Phrase: "karyotypic deletions of chromosome 5."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   851   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]
Processing 00000000.tx.24: The primary mechanism of loss of chromosome 5and 17sequences was by an unbalanced translocation between the 2chromosomes (9/15 cases). 

Phrase: "The primary mechanism of loss of chromosome 5and 17sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441712:Mechanism [Functional Concept]
   742   C1706376:Mechanism [Manufactured Object]

Phrase: "was by an unbalanced translocation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1519758:Unbalanced Translocation [Cell or Molecular Dysfunction]
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C2987521:Translocation [Activity]

Phrase: "between the 2chromosomes"

Phrase: "(9/15 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.25: Unbalanced translocations or dicentrics involving chromosomes 5and 17have been recognized as recurring abnormalities in myeloid neoplasms by other investigators as well.13 The nonrandom participation of chromosome 5raises the possibility of an unidentified gene on chromosome 5whose loss synergizes with the inactivation of the TP53 gene. 

Phrase: "Unbalanced translocations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1519758:Unbalanced Translocation [Cell or Molecular Dysfunction]
   861   C0040715:Translocations [Cell or Molecular Dysfunction]
   827 E C2987521:Translocation [Activity]

Phrase: "or"

Phrase: "dicentrics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333710:Dicentric [Cell or Molecular Dysfunction]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "chromosomes 5and 17have"

Phrase: "been"

Phrase: "recognized as recurring abnormalities"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   770   C0034897:recurring [Phenomenon or Process]
   770   C2945760:Recurring [Temporal Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "in myeloid neoplasms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2939461:Myeloid neoplasm [Neoplastic Process]
   861   C0027651:NEOPLASMS, NOS [Neoplastic Process]
   827 E C2981607:NEOPLASM [Intellectual Product]

Phrase: "by other investigators"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035173:Investigators [Professional or Occupational Group]

Phrase: "as well.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "The nonrandom participation of chromosome 5raises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679823:Participation [Functional Concept]

Phrase: "the possibility of an unidentified gene"

Phrase: "on chromosome 5whose loss"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0598174:chromosome loss [Genetic Function]
   877 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]
   827   C1517945:Loss [Quantitative Concept]

Phrase: "synergizes with the inactivation of the TP53 gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1515171:TP53 Gene Inactivation [Cell or Molecular Dysfunction]
   770   C0079419:TP53 gene [Gene or Genome]
   767   C0598496:Gene Inactivation [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0544461:Inactivation [Cell or Molecular Dysfunction]
Processing 00000000.tx.26: Because most of these patients have numerous cytogenetic abnormalities at presentation, it is difficult to determine whether the mutation in the TP53 gene occurs first and the unbalanced 5;17 translocation results from the ensuing genomic instability, or whether the der(5;17) is an initial, critical step. 

Phrase: "Because"

Phrase: "most of these patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205393:Most [Quantitative Concept]

Phrase: "have"

Phrase: "numerous cytogenetic abnormalities at presentation,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0008625:Cytogenetic Abnormalities [Cell or Molecular Dysfunction]
   806   C0008626:Cytogenetic Abnormalities [Disease or Syndrome]
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "determine"

Phrase: "whether"

Phrase: "the mutation in the TP53 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "and"

Phrase: "the unbalanced 5"

Phrase: ";17 translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "results from the ensuing genomic instability,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0919532:Genomic Instability [Cell or Molecular Dysfunction]
   753   C0017428:Genomic [Gene or Genome]
   753   C0887950:genomic [Biomedical Occupation or Discipline]
   753   C1274040:Result [Functional Concept]
   753   C1444783:Instability [Finding]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "or"

Phrase: "whether"

Phrase: "the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "is"

Phrase: "an initial, critical step."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]
Processing 00000000.tx.27: In this report, we show that a putative tumor suppressor locus at 5q13.3 may be the target of a critical gene because patient samples with a mutated TP53 allele also have invariant loss or disruption of 5q13.3. 

Phrase: "In this report,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a putative tumor suppressor locus at 5q13.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "the target of a critical gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1332838:Target Gene [Gene or Genome]
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "because"

Phrase: "patient samples with a mutated TP53 allele also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "have"

Phrase: "invariant loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "or"

Phrase: "disruption of 5q13.3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.28: Thus, loss of chromosome 5q13.3 sequences confers a proliferative advantage to a dysplastic clone that can be fully transformed upon acquiring a mutation in the TP53 gene.  

Phrase: "Thus,"

Phrase: "loss of chromosome 5q13.3 sequences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   864   C1517980:Loss of Chromosome 3 [Cell or Molecular Dysfunction]
   783   C0598174:chromosome loss [Genetic Function]
   753   C1517945:Loss [Quantitative Concept]
   748 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]

Phrase: "confers"

Phrase: "a proliferative advantage to a dysplastic clone"

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "fully"

Phrase: "transformed upon acquiring"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0439661:acquiring [Temporal Concept]
   790   C1510411:Transformed [Pathologic Function]
   756 E C1706701:Acquire [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "a mutation in the TP53 gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.29: Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Patient samples All patient information and samples were obtained through approved protocols. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patient samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "All patient information"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1955348:Patient Information [Intellectual Product]
  1000   C2598117:Patient Information [Clinical Attribute]
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained through approved protocols."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   816   C2346846:Approved Protocol [Functional Concept]
   770   C0205540:Approved [Qualitative Concept]
   770   C0442711:Protocols [Intellectual Product]
   770   C1301820:Obtained [Functional Concept]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737 E C1706701:Obtain [Activity]
   737 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.30: Routine cytogenetic analysis were performed on patients when they were seen at the University of Texas M.D.

Phrase: "Routine cytogenetic analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0752095:Cytogenetic Analysis [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed on patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "when"

Phrase: "they"

Phrase: "were"

Phrase: "seen at the University of Texas M.D."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C1512018:M.D. [Intellectual Product]
   744   C0039711:Texas [Geographic Area]
   744   C0041740:University [Manufactured Object,Organization]
   744   C0205397:Seen [Qualitative Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]
Processing 00000000.tx.31: Anderson Cancer Center. 

Phrase: "Anderson Cancer Center."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]
Processing 00000000.tx.32: Patient 1was treated at the University of Texas M.D.

Phrase: "Patient 1was"

Phrase: "treated at the University of Texas M.D."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C1512018:M.D. [Intellectual Product]
   744   C0039711:Texas [Geographic Area]
   744   C0041740:University [Manufactured Object,Organization]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.33: Anderson Cancer Center for acute promyelocytic leukemia with a typical t(15;17)(q22;q21) in January 1994.She went into complete remission by July 1994in response to all trans retinoic acid and idarubicin. 

Phrase: "Anderson Cancer Center for acute promyelocytic leukemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1513817:Cancer Center [Health Care Related Organization]
   748   C0205099:Center [Spatial Concept]

Phrase: "with a typical t(15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538928:Typical [Qualitative Concept]

Phrase: ";17"

Phrase: ")"

Phrase: "(q22"

Phrase: ";q21"

Phrase: ")"

Phrase: "in January 1994."

Phrase: "She"

Phrase: "went into complete remission"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0677874:Complete Remission [Finding]
   770   C0205197:Complete [Qualitative Concept]
   770   C0544452:Remission [Finding]
   770   C0687702:remission [Neoplastic Process]
   770   C0725685:COMPLEAT [Food]

Phrase: "by July 1994in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "to all trans retinoic acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0040845:all-trans-Retinoic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
           trans-Retinoic Acid
           Retinoic Acid
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0444868:All [Quantitative Concept]
   812   C2826298:TRANS [Idea or Concept]
   812   C3539085:All [Idea or Concept]

Phrase: "and"

Phrase: "idarubicin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020789:Idarubicin [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.34: An abnormal clone with 45,XX,-5, add(17)(p11.2) was first identified by conventional G-banding during routine follow-up in July 1996.

Phrase: "An abnormal clone with 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009013:Clone [Cell]
   760   C1522642:Clone [Tissue]

Phrase: "XX,-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450371:XX [Organism Attribute]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "add(17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "(p11.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0966870:p11 [Amino Acid, Peptide, or Protein,Receptor]
   861   C3538774:P11 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified by conventional G-banding"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C1517334:G-Banding [Laboratory Procedure]
   760   C0185014:Banding [Therapeutic or Preventive Procedure]
   760   C0205396:Identified [Qualitative Concept]
   760   C0439267:g% [Quantitative Concept]
   760   C0439858:Conventional [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C0175723:Band [Medical Device]
   726 E C0439645:Band [Spatial Concept]
   726 E C1521913:band [Cell Component]

Phrase: "during routine follow-up"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0589120:Follow-up [Finding]
   901   C1522577:follow-up [Health Care Activity]
   901   C1704685:FOLLOW-UP [Intellectual Product]
   901   C3274571:FOLLOW-UP [Health Care Activity]
   827   C0332283:follow [Temporal Concept]
   827   C1719822:Follow [Intellectual Product]

Phrase: "in July 1996."
Processing 00000000.tx.35: The -5,add(17p) anomaly was later determined to be a der(5;17) by FISH. 

Phrase: "The -5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "add(17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0796349:17p [Nucleotide Sequence]
   861   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "anomaly"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1704258:Anomaly [Finding]
   928 E C3277934:Anomalous [Finding]

Phrase: "was"

Phrase: "later"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "by FISH."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0162789:Fluorescent in Situ Hybridization [Molecular Biology Research Technique]
   923   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   861   C0444498:In situ [Spatial Concept]
   812   C0020202:Hybridisation [Genetic Function]
   812   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1300517:Hybridization [Laboratory Procedure]
Processing 00000000.tx.36: In December 1996,she presented with 9% blasts in her bone marrow, an abnormal karyotype with multiple cytogenetic changes, including the der(5;17), and was diagnosed with MDS. 

Phrase: "In December 1996,"

Phrase: "she"

Phrase: "presented with 9% blasts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0337026:blasts [Natural Phenomenon or Process]
   770   C0368761:Blasts [Cell]
   770   C0449450:Presented [Idea or Concept]
   770   C0523113:Blasts [Laboratory Procedure]
   737 E C0150312:Present [Quantitative Concept]

Phrase: "in her bone marrow,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
  1000   C0005953:Bone Marrow [Tissue]
   861   C0086590:Marrow [Food]
   861   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   861   C0376152:Marrow [Body Part, Organ, or Organ Component]
   861   C0391978:Bone [Tissue]
   861   C1266908:Bone [Body Part, Organ, or Organ Component]
   861   C1266909:Bone [Body System]
   861   C1546708:Marrow [Intellectual Product]
   805 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   805 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   805 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   789 E C0443157:Bony [Functional Concept]
   777 E C0330477:Marrows [Plant]

Phrase: "an abnormal karyotype with multiple cytogenetic changes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0476431:Abnormal Karyotype [Finding]
   748   C0022526:Karyotype [Laboratory Procedure]
   748   C0178725:Karyotype [Laboratory or Test Result]
   748   C1261273:Karyotype [Organism Attribute]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "was"

Phrase: "diagnosed with MDS."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011900:Diagnosed [Finding]
   790   C0026985:Myelodysplasia [Congenital Abnormality]
   790   C0026986:Myelodysplasia [Neoplastic Process]
   790   C0033027:myelodysplasia [Neoplastic Process]
Processing 00000000.tx.37: Patient database Information on patients treated at the M.D.

Phrase: "Patient database Information on patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1955348:Patient Information [Intellectual Product]
   797   C2598117:Patient Information [Clinical Attribute]
   760   C1533716:Information [Idea or Concept]

Phrase: "treated at the M.D."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1512018:M.D. [Intellectual Product]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.38: Anderson Cancer Center, Houston, TX, in the Department of Hematology since 1985is available in a departmental database (Microsoft Access). 

Phrase: "Anderson Cancer Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "Houston,"

Phrase: "TX,"

Phrase: "in the Department"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704729:Department [Organization]

Phrase: "of Hematology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
  1000   C0200627:HEMATOLOGY [Laboratory Procedure]
   928 E C0205488:Haematologic [Functional Concept]

Phrase: "since"

Phrase: "1985is"

Phrase: "available in a departmental database"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0470187:Available [Functional Concept]

Phrase: "(Microsoft Access"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0444454:Access [Spatial Concept]
   861   C1554204:access [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.39: Karyotypic data are available for 2718patients that have been diagnosed with AML or MDS. 

Phrase: "Karyotypic data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "available for 2718patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "diagnosed with AML"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   806   C0023470:Myelogenous Leukemia [Neoplastic Process]
   797   C0085669:Acute leukaemia [Neoplastic Process]
   797   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   760   C0011900:Diagnosed [Finding]
   760   C0023418:Leukaemia [Neoplastic Process]
   760   C0205178:acute [Temporal Concept]
   760   C0439677:Myelogenous [Qualitative Concept]

Phrase: "or"

Phrase: "MDS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]
Processing 00000000.tx.40: Routine cytogenetic analysis was performed on patients at presentation as part of the diagnostic procedure. 

Phrase: "Routine cytogenetic analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0752095:Cytogenetic Analysis [Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed on patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "at presentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449450:Presentation [Idea or Concept]

Phrase: "as part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the diagnostic procedure."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0430022:diagnostic procedure [Diagnostic Procedure]
  1000   C1546908:Diagnostic procedure [Functional Concept]
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.41: Patients were identified as having specific chromosomal abnormalities by searching for the following strings in the database: "-5", "*del(5*", "*5q*", *(5;*", "*;5)", "-7", "*del(7*", "*7q*", "*(7;*", "*;7)*", "*,-17*", "*del(17*", "*17p*", "*(17;*", "*;17)*", "*add(17*", "*,-16*", "*del(16*", "*(16;*", "*16;)*", "*inv(16)*", or "*inv16*". 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "having"

Phrase: "specific chromosomal abnormalities by searching"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   806   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]

Phrase: "for the following strings"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0183652:strings [Medical Device]
   827 E C1547402:String [Idea or Concept]
   827 E C3540771:String [Intellectual Product]
   755 E C1704523:Stringiness [Finding]

Phrase: "in the database"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242356:Database [Intellectual Product]
  1000   C0993637:Data Base [Intellectual Product]

Phrase: ":"

Phrase: """-5"","
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: """"

Phrase: "*del(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008628:del [Cell or Molecular Dysfunction]

Phrase: "*"","

Phrase: """"

Phrase: "*5q"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796347:5q [Nucleotide Sequence]
  1000   C1521461:5q- [Cell or Molecular Dysfunction]

Phrase: "*"","

Phrase: "*"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ";"

Phrase: "*"","

Phrase: """"

Phrase: "*"

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ""","

Phrase: """-7"","

Phrase: """"

Phrase: "*del(7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008628:del [Cell or Molecular Dysfunction]

Phrase: "*"","

Phrase: """"

Phrase: "*7q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796361:7q [Nucleotide Sequence]

Phrase: "*"","

Phrase: """"

Phrase: "*"

Phrase: "(7"

Phrase: ";"

Phrase: "*"","

Phrase: """"

Phrase: "*"

Phrase: ";7"

Phrase: ")"

Phrase: "*"","

Phrase: """"

Phrase: "*,-"

Phrase: "17"

Phrase: "*"","

Phrase: """"

Phrase: "*del(17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008628:del [Cell or Molecular Dysfunction]

Phrase: "*"","

Phrase: """"

Phrase: "*17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "*"","

Phrase: """"

Phrase: "*"

Phrase: "(17"

Phrase: ";"

Phrase: "*"","

Phrase: """"

Phrase: "*"

Phrase: ";17"

Phrase: ")"

Phrase: "*"","

Phrase: """"

Phrase: "*add(17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883712:Add [Functional Concept]

Phrase: "*"","

Phrase: """"

Phrase: "*,-"

Phrase: "16"

Phrase: "*"","

Phrase: """"

Phrase: "*del(16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008628:del [Cell or Molecular Dysfunction]

Phrase: "*"","

Phrase: """"

Phrase: "*"

Phrase: "(16"

Phrase: ";"

Phrase: "*"","

Phrase: """"

Phrase: "*16"

Phrase: ";"

Phrase: ")"

Phrase: "*"","

Phrase: """"

Phrase: "*inv(16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021943:inv [Cell or Molecular Dysfunction]
   861   C1425144:INV [Gene or Genome]

Phrase: ")"

Phrase: "*"","

Phrase: "or ""*inv16"

Phrase: "*""."
Processing 00000000.tx.42: Searches explicitly excluded t(15;17). 

Phrase: "Searches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552603:search [Intellectual Product]
  1000   C1706202:Search [Activity]

Phrase: "explicitly excluded t(15"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C1554077:Excluded [Idea or Concept]
   812   C2828389:Excluded [Activity]
   779 E C0332196:Exclude [Functional Concept]

Phrase: ";17"

Phrase: ")."
Processing 00000000.tx.43: Searches were performed for each chromosome alone and then in various combinations. 

Phrase: "Searches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552603:search [Intellectual Product]
   966   C1706202:Search [Activity]

Phrase: "were"

Phrase: "performed for each chromosome"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0008633:Chromosome [Cell Component]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "then in various combinations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C0453882:Combinations [Manufactured Object]
   770   C1883708:Then [Temporal Concept]
   737 E C0205195:Combination [Qualitative Concept]
   737 E C1947911:Combination [Physical Object]
Processing 00000000.tx.44: Each karyotype was reviewed to ensure that the string search accurately identified chromosomal changes involving 5q, 7q, and 17p. 

Phrase: "Each karyotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022526:Karyotype [Laboratory Procedure]
  1000   C0178725:Karyotype [Laboratory or Test Result]
  1000   C1261273:Karyotype [Organism Attribute]

Phrase: "was"

Phrase: "reviewed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewed [Intellectual Product]
  1000   C1709940:Reviewed [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the string search accurately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "chromosomal changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "5q,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796347:5q [Nucleotide Sequence]
  1000   C1521461:5q- [Cell or Molecular Dysfunction]

Phrase: "7q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0796361:7q [Nucleotide Sequence]

Phrase: "and"

Phrase: "17p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]
Processing 00000000.tx.45: Loss of heterozygosity (LOH) analysis Information for the polymorphic markers that were used in this study was obtained from the Whitehead Institute (http://www.genome.wi.mit.edu) or the Stanford Human Genome Center (SHGC) (http://www-shgc.stanford.edu). 

Phrase: "Loss of heterozygosity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   790   C1517945:Loss [Quantitative Concept]

Phrase: "(LOH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   790   C1517945:Loss [Quantitative Concept]

Phrase: ")"

Phrase: "analysis Information for the polymorphic markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1955169:Analysis information [Clinical Attribute]
   753   C1533716:Information [Idea or Concept]

Phrase: "that"

Phrase: "were"

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "obtained from the Whitehead Institute"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0021622:institute [Organization]
   760   C0302302:Whitehead [Pathologic Function]
   760   C1272753:Institute [Idea or Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.genome.wi.mit.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "the Stanford Human Genome Center (SHGC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www-shgc.stanford.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.46: Primers and polymerase chain reaction (PCR) amplification conditions for chromosome 5and 17markers were obtained from the Genome Database (http://www.gdb.org), the Whitehead institute, or the SHGC. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "polymerase chain reaction (PCR) amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "conditions for chromosome 5and 17markers"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0008633:Chromosome [Cell Component]
   760   C0012634:condition [Disease or Syndrome]
   760   C0348080:Condition [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "were"

Phrase: "obtained from the Genome Database"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0872346:genome database [Intellectual Product]
   760   C0017428:Genome [Gene or Genome]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1301820:Obtained [Functional Concept]
   760   C2338314:Genome [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: "(http"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555015:HTTP [Idea or Concept]

Phrase: ":"

Phrase: "//www.gdb.org"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1522486:ORG [Professional or Occupational Group]

Phrase: ")"

Phrase: ","

Phrase: "the Whitehead institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "or"

Phrase: "the SHGC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]
Processing 00000000.tx.47: The technique for determining LOH is detailed elsewhere.14 Physical map of 5q13.3 loci Our previous report on the delineation of the critical 5q13.3 locus relied solely on the radiation hybrid mapping data available at that time from the Whitehead Institute. 

Phrase: "The technique for determining LOH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449851:Technique [Functional Concept]

Phrase: "is"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "elsewhere.14 Physical map of 5q13.3 loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0599777:physical map [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0024779:Map [Manufactured Object]
   744   C1706473:Map [Conceptual Entity]

Phrase: "Our previous report on the delineation of the critical 5q13.3 locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0684224:Report [Intellectual Product]
   736   C0700287:Report [Health Care Activity]
   736   C3273238:Report [Intellectual Product]

Phrase: "relied"

Phrase: "solely on the radiation hybrid mapping data"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   814   C0887810:Radiation Hybrid Mapping [Molecular Biology Research Technique]
   797 E C1253949:Radiation Hybrid Map [Intellectual Product]
   778   C0887811:Radiation Hybrid [Cell]
   748   C0020205:Hybrid [Organism]
   748   C0034519:Radiation [Natural Phenomenon or Process]
   748   C0560559:Radiation [Quantitative Concept]
   748   C0851346:Radiation [Natural Phenomenon or Process]
   748   C1283195:Mapping [Activity]
   748   C1511726:Data [Idea or Concept]
   748   C1522449:Radiation [Therapeutic or Preventive Procedure]
   748   C1524020:Radiation [Therapeutic or Preventive Procedure]
   748   C1524021:Radiation [Research Activity]
   748   C3245479:data [Medical Device]
   714 E C0024779:Map [Manufactured Object]
   714 E C1706473:Map [Conceptual Entity]

Phrase: "available at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0470187:Available [Functional Concept]

Phrase: "that time from the Whitehead Institute."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
Processing 00000000.tx.48: The current study was facilitated by second generation radiation hybrid maps from the SHGC, Sanger Center. 

Phrase: "The current study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "facilitated by second generation radiation hybrid maps"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   814   C1253949:Radiation Hybrid Maps [Intellectual Product]
   778   C0887811:Radiation Hybrid [Cell]
   748   C0020205:Hybrid [Organism]
   748   C0024779:Map [Manufactured Object]
   748   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0034519:Radiation [Natural Phenomenon or Process]
   748   C0079411:Generation [Temporal Concept]
   748   C0205436:Second [Quantitative Concept]
   748   C0457385:Second [Temporal Concept]
   748   C0560559:Radiation [Quantitative Concept]
   748   C0565930:/second [Quantitative Concept]
   748   C0851346:Radiation [Natural Phenomenon or Process]
   748   C1522449:Radiation [Therapeutic or Preventive Procedure]
   748   C1524020:Radiation [Therapeutic or Preventive Procedure]
   748   C1524021:Radiation [Research Activity]
   748   C1561503:second [Idea or Concept]
   748   C1705190:Second [Qualitative Concept]
   748   C1706473:Map [Conceptual Entity]
   748   C3146294:Generation [Activity]

Phrase: "from the SHGC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "Sanger Center."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]
Processing 00000000.tx.49: UK, and a Yeast Artificial Chromosome (YAC) contig from the Whitehead Institute. 

Phrase: "UK,"

Phrase: "and"

Phrase: "a Yeast Artificial Chromosome (YAC) contig from the Whitehead Institute."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1511491:Contig [Spatial Concept]
Processing 00000000.tx.50: All the markers were verified independently against the YACs. 

Phrase: "All"

Phrase: "the markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "were"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: "independently against the YACs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0206665:YAC [Research Device]
Processing 00000000.tx.51: Only those markers that tested positive in 2or more screens were considered truly positive. 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "those markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "that tested positive in 2or more screens"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439178:% Positive [Quantitative Concept]
   748   C1446409:Positive [Qualitative Concept]
   748   C1514241:Positive [Finding]
   748   C2825490:Positive [Qualitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "truly positive."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.52: Orientation and overlap of the YACs were further confirmed by screening for ends of YACs rescued by inverse PCR.15 The current order is most consistent with centromere-AFMb347yf9-D5S672-D5S620/D5S626-D5S641-GATAP18 104-D5S401-telomere, rather than the previous order of centromere-D5S672-AFMb347yf9-GATAP18 104-D5S620/D5S626-D5S641-D5S401-telomere. 

Phrase: "Orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0029266:Orientation [Mental Process]
  1000   C1704322:orientation [Spatial Concept]
  1000   C1704972:Orientation [Spatial Concept]
  1000   C3539923:Orientation [Intellectual Product]

Phrase: "and"

Phrase: "overlap of the YACs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0185027:overlap [Therapeutic or Preventive Procedure]
   770   C1948020:Overlap [Conceptual Entity]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "confirmed by screening"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0220908:Screening [Health Care Activity]
   790   C0220909:screening [Functional Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C1698960:screening [Intellectual Product]
   790   C1710031:Screening [Diagnostic Procedure]
   790   C1710477:SCREENING [Research Activity]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "for ends"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0444930:ends [Spatial Concept]
   966 E C2746065:End [Temporal Concept]
   928 E C0205088:Terminal [Temporal Concept]
   928 E C1705314:Terminal [Manufactured Object]
   928 E C1705315:Terminal [Spatial Concept]

Phrase: "of YACs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206665:YAC [Research Device]

Phrase: "rescued by inverse PCR.15"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   853   C0079639:Inverse Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0337112:Chain [Manufactured Object]
   748   C0439850:Inverse [Qualitative Concept]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1524075:Chain [Idea or Concept]

Phrase: "The current order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "is"

Phrase: "most consistent"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0332290:Consistent [Idea or Concept]
   789 E C0332529:Consistencies [Qualitative Concept]
   789 E C1547017:Consistency [Quantitative Concept]

Phrase: "with centromere-AFMb347yf9-D5S672-D5S620/D5S626-D5S641-GATAP18 104-D5S401-telomere,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0085187:telomere [Cell Component]

Phrase: "rather than"

Phrase: "the previous order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "of centromere-D5S672-AFMb347yf9-GATAP18 104-D5S620/D5S626-D5S641-D5S401-telomere."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0085187:telomere [Cell Component]
Processing 00000000.tx.53: Inclusion of additional sequence tagged site (STS) markers D5S1464, D5S806, D5S2029 enhances the resolution of the map. 

Phrase: "Inclusion of additional sequence tagged site (STS) markers D5S1464,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1512693:Inclusion [Qualitative Concept]

Phrase: "D5S806,"

Phrase: "D5S2029"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the resolution of the map."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514893:Resolution [Idea or Concept]
   760   C1706463:Resolution [Quantitative Concept]
   760   C2699488:Resolution [Conceptual Entity]
Processing 00000000.tx.54: Somatic cell hybrids Somatic cell hybrids were generated by fusing the peripheral blood leukemic blasts from patient 1and LMTK- murine fibroblasts. 

Phrase: "Somatic cell hybrids Somatic cell hybrids"

Phrase: "were"

Phrase: "generated by fusing"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0699952:fusing [Functional Concept]
   790   C3146294:Generated [Activity]
   756 E C1414861:FUSE [Gene or Genome]
   756 E C1708111:Fuse [Manufactured Object]

Phrase: "the peripheral blood leukemic blasts from patient 1and LMTK- murine fibroblasts."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C2697913:Leukemic Blasts [Laboratory Procedure]
   738   C0337026:blasts [Natural Phenomenon or Process]
   738   C0368761:Blasts [Cell]
   738   C0523113:Blasts [Laboratory Procedure]
Processing 00000000.tx.55: Ficoll Hypaque separated mononuclear cells in suspension were fused with polyethylene glycol (PEG 1000) and selected in hypoxanthine, aminopterin, and thymidine (HAT) containing medium.16 Colonies were screened by PCR to identify those with human chromosome 5and 17sequences. 

Phrase: "Ficoll Hypaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813724:Hypaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "mononuclear cells in suspension"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0806987:Mononuclear cells [Cell]
   770   C0007634:Cells [Cell]
   770   C1513475:Mononuclear [Clinical Attribute]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "fused with polyethylene glycol"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0032483:Polyethylene Glycol [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0017945:Glycol [Organic Chemical]
   770   C0017951:Glycol [Organic Chemical]
   770   C0032487:polyethylene [Biomedical or Dental Material,Organic Chemical]
   770   C0137914:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   770   C0699952:Fused [Functional Concept]
   770   C0752345:Polyethylene [Biomedical or Dental Material,Organic Chemical]
   737 E C1414861:FUSE [Gene or Genome]
   737 E C1708111:Fuse [Manufactured Object]

Phrase: "(PEG 1000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030773:PEG 1000 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "selected in hypoxanthine,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020684:Hypoxanthine [Biologically Active Substance,Organic Chemical]
   756   C1707391:Select [Activity]

Phrase: "aminopterin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002583:Aminopterin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "thymidine (HAT) containing medium.16 Colonies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439158:colonies [Quantitative Concept]
   771 E C1947989:Colony [Cell]

Phrase: "were"

Phrase: "screened by PCR to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   719   C0220908:screen [Health Care Activity]
   719   C1305399:screen [Functional Concept]
   719   C1705053:Screen [Medical Device]

Phrase: "identify"

Phrase: "those with human chromosome 5and 17sequences."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0008643:Human Chromosome [Cell Component]
   753   C0008633:Chromosome [Cell Component]
   753   C0086418:Human [Human]
Processing 00000000.tx.56: Cell lines The AML cell line ML3 was cultured in RPMI 1640medium (Life Technologies, Rockville, MD) containing 10% fetal calf serum. 

Phrase: "Cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "The AML cell line ML3"

Phrase: "was"

Phrase: "cultured in RPMI 1640medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Rockville,"

Phrase: "MD)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal calf serum."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.57: LMTK- mouse fibroblasts were cultured in Dulbecco's Modified Eagle medium (DMEM) (Life Technologies, Rockville, MD) containing 10% fetal calf serum. 

Phrase: "LMTK- mouse fibroblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "cultured in Dulbecco's Modified Eagle medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "(DMEM"

Phrase: ")"

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Rockville,"

Phrase: "MD)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal calf serum."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]
Processing 00000000.tx.58: Fluorescence in situ hybridization Alu PCR probes were made by PCR amplifying against YAC DNA. 

Phrase: "Fluorescence in situ hybridization Alu PCR probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   855   C0016321:Fluorescent Probes [Indicator, Reagent, or Diagnostic Aid]
   791   C0182400:Probes [Medical Device]
   758 E C1704681:Probe [Gene or Genome]
   758 E C2347609:Probe [Chemical Viewed Functionally]
   758 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "made by PCR amplifying"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0337112:Chain [Manufactured Object]
   753   C0443286:Reaction [Functional Concept]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1524075:Chain [Idea or Concept]
   719   C1881534:Make [Functional Concept]

Phrase: "against YAC DNA."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   825   C2331150:Chromosomal DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C0206665:Yeast Artificial Chromosome [Research Device]
Processing 00000000.tx.59: Primers and amplification conditions are described by Liu et al.17 Probes were biotinylated using Bionick Labeling System (Life Technologies, Rockville, MD) according to the manufacturer's instructions. 

Phrase: "Primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "amplification conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "are"

Phrase: "described by Liu et al.17 Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   748   C0182400:Probes [Medical Device]
   748   C1552738:described [Idea or Concept]
   714 E C1704681:Probe [Gene or Genome]
   714 E C2347609:Probe [Chemical Viewed Functionally]
   714 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "biotinylated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Bionick Labeling System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Rockville,"

Phrase: "MD) according to the manufacturer's instructions."
Processing 00000000.tx.60: Painting probes were purchased from Oncor (Gaithersberg, MD). 

Phrase: "Painting probes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "were"

Phrase: "purchased from Oncor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "(Gaithersberg,"

Phrase: "MD)."
Processing 00000000.tx.61: Hybridization procedures are detailed elsewhere.18 Mutation screening for the TP53 gene The TP53 exons 4-8were amplified with intronic primers and the products were sequenced in an ABI 377automated DNA sequencer using standard dye terminator chemistry. 

Phrase: "Hybridization procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "are"

Phrase: "detailed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Detailed [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]

Phrase: "elsewhere.18 Mutation screening for the TP53 gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0220908:Screening [Health Care Activity]
   744   C0220909:screening [Functional Concept]
   744   C1698960:screening [Intellectual Product]
   744   C1710031:Screening [Diagnostic Procedure]
   744   C1710477:SCREENING [Research Activity]

Phrase: "The TP53 exons 4-8were"

Phrase: "amplified with intronic primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "sequenced in an ABI 377automated DNA sequencer"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0162326:DNA Sequence [Nucleotide Sequence]
           Sequence
   748   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1328319:ABI [Clinical Attribute]
   714   C0004793:Sequence [Nucleotide Sequence]
   714   C0162327:Sequence [Nucleotide Sequence]
   714   C1519249:Sequence [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard dye terminator chemistry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0007996:Chemistry [Occupation or Discipline]
   812   C0079107:chemistry [Classification]
   812   C0201682:Chemistry [Laboratory Procedure]
Processing 00000000.tx.62: Mutations were verified by at least 2independent PCR amplifications.  

Phrase: "Mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "verified by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1711411:Verified [Functional Concept]

Phrase: "at least 2independent PCR amplifications."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0337112:Chain [Manufactured Object]
   799   C0443286:Reaction [Functional Concept]
   799   C1114821:Reaction [Clinical Attribute]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1524075:Chain [Idea or Concept]
   766   C1517480:Amplification [Molecular Biology Research Technique]
   766   C1521871:Amplification [Phenomenon or Process]
   766   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.63: Results Top Abstract Introduction Materials and methods Results Discussion References Deletions of chromosomes 5and 17cosegregate in RAEB, RAEB-t, and AML patients We noted that 6of the 12patients who allowed the initial delineation of the critical 5q13.3 locus also had deletions of 17p or monosomy for chromosome 17.1 To determine whether this was due to a selection bias or a nonrandom correlation, we used our institutional database that contains karyotypic data for AML and MDS patients. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Deletions of chromosomes 5and 17cosegregate"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   840   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "in RAEB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002894:RAEB [Neoplastic Process]

Phrase: "RAEB-t,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0280028:RAEB-T [Disease or Syndrome]
   861   C0002894:RAEB [Neoplastic Process]

Phrase: "and"

Phrase: "AML patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0030705:Patients [Patient or Disabled Group]
   756   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   708   C0085669:Acute leukaemia [Neoplastic Process]
   708   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]

Phrase: "We"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "that 6of"

Phrase: "the 12patients"

Phrase: "who"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the initial delineation of the critical 5q13.3 locus also"

Phrase: "had"

Phrase: "deletions of 17p"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1880274:Deletions [Activity]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]

Phrase: "or"

Phrase: "monosomy for chromosome 17.1 To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1513480:Monosomy 17 [Cell or Molecular Dysfunction]
   753   C0026499:Monosomy [Congenital Abnormality]

Phrase: "determine"

Phrase: "whether"

Phrase: "this"

Phrase: "was due to a selection bias"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0036577:Selection Bias [Quantitative Concept]
   790   C0678226:Due to [Functional Concept]
           due
   753   C0036576:selection [Genetic Function]
   753   C0043194:WAS [Disease or Syndrome]
   753   C0242568:Bias [Idea or Concept]
   753   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1421478:WAS [Gene or Genome]
   753   C1504315:Bias [Bird]
   753   C3146286:Due [Idea or Concept]
   719 E C1061346:Bia [Eukaryote]
   719 E C1704746:BIA [Diagnostic Procedure]

Phrase: "or"

Phrase: "a nonrandom correlation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "our institutional database"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242356:Database [Intellectual Product]
   861   C0993637:Data Base [Intellectual Product]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "karyotypic data for AML"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "MDS patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.64: The overall frequency of loss of 5,7,and 17were 11.3%, 13.4%, and 5.97%, respectively. 

Phrase: "The overall frequency of loss of 5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "7,"

Phrase: "and"

Phrase: "17were 11.3%,"

Phrase: "13.4%,"

Phrase: "and"

Phrase: "5.97%,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.65: Of those 350patients with chromosome 5abnormalities, 134(38%) had a chromosome 17abnormality and 161(46%) had a chromosome 7abnormality. 

Phrase: "Of those 350patients"

Phrase: "with chromosome 5abnormalities,"

Phrase: "134"

Phrase: "(38%"

Phrase: ")"

Phrase: "had"

Phrase: "a chromosome 17abnormality"

Phrase: "and"

Phrase: "161"

Phrase: "(46%"

Phrase: ")"

Phrase: "had"

Phrase: "a chromosome 7abnormality."
Processing 00000000.tx.66: The correlation between chromosomes 5and 17is similar to that seen between chromosomes 5and 719 (Figure 1). 

Phrase: "The correlation between chromosomes 5and 17is"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707520:Correlation [Qualitative Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "seen between chromosomes 5and 719"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0008633:Chromosomes [Cell Component]
   760   C0205397:Seen [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "(Figure 1"

Phrase: ")."
Processing 00000000.tx.67: No other chromosomal abnormality showed such a strong cosegregation. 

Phrase: "No"

Phrase: "other chromosomal abnormality"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0008625:Chromosomal Abnormality [Cell or Molecular Dysfunction]
  1000   C0008626:Chromosomal Abnormality [Disease or Syndrome]
   861   C1704258:Abnormality [Finding]
   789 E C0205161:Abnormal [Qualitative Concept]
   789 E C2347472:% Abnormal [Quantitative Concept]
   789 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "such a strong cosegregation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986591:Cosegregation [Functional Concept]
Processing 00000000.tx.68: For example, anomalies of the long arm of chromosome 16,which is reported to show allelic imbalance in solid tumors,20 are seen only in 55(16%) of the 350patients with chromosome 5anomalies. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "anomalies of the long arm of chromosome 16,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   782   C0008626:Anomaly of chromosome [Disease or Syndrome]
           anomalies chromosome
   767   C0008625:Chromosome Anomalies [Cell or Molecular Dysfunction]
   744   C0000769:anomalies [Functional Concept]
   711 E C1704258:Anomaly [Finding]

Phrase: "which"

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "allelic imbalance in solid tumors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0887935:Allelic Imbalance [Cell or Molecular Dysfunction]
   760   C1397014:Imbalance [Sign or Symptom]

Phrase: "20"

Phrase: "are"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "only in 55"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Only [Quantitative Concept]
   790   C0450382:55 [Intellectual Product]
   790   C1720467:Only [Intellectual Product]

Phrase: "(16%"

Phrase: ")"

Phrase: "of the 350patients"

Phrase: "with chromosome 5anomalies."
Processing 00000000.tx.69: Additionally, none of the 55patients with the anomaly inv(16) that is associated with the M4 subtype of AML had loss of chromosome 5.

Phrase: "Additionally,"

Phrase: "none of the 55patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]

Phrase: "with the anomaly inv(16"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0021943:inv [Cell or Molecular Dysfunction]
   827   C1425144:INV [Gene or Genome]
   827   C1704258:Anomaly [Finding]
   755 E C3277934:Anomalous [Finding]

Phrase: ")"

Phrase: "that"

Phrase: "is"

Phrase: "associated with the M4 subtype of AML"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   764   C0023470:Myelogenous Leukemia [Neoplastic Process]
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   762   C0085669:Acute leukaemia [Neoplastic Process]
   762   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   742   C0023418:Leukaemia [Neoplastic Process]
   742   C0205178:acute [Temporal Concept]
   742   C0439677:Myelogenous [Qualitative Concept]
   742   C0449560:Subtype [Classification]
   742   C1550077:M4 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   742   C1561479:M4 [Intellectual Product]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "had"

Phrase: "loss of chromosome 5."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1517985:Loss of Chromosome 5 [Cell or Molecular Dysfunction]
   819   C0598174:chromosome loss [Genetic Function]
   783 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]
   770   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.70: Thus, there is a nonrandom cosegregation of deletions of chromosome 5q and 17p loci in AML and MDS. 

Phrase: "Thus,"

Phrase: "there"

Phrase: "is"

Phrase: "a nonrandom cosegregation of deletions of chromosome 5q"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2986591:Cosegregation [Functional Concept]

Phrase: "and"

Phrase: "17p loci in AML"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "MDS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]
Processing 00000000.tx.71: View larger version (10K): [in this window] [in a new window]  Fig 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.72: Chromosomal abnormalities of patients with AML or MDS. 

Phrase: "Chromosomal abnormalities of patients"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0008625:Abnormalities, Chromosomal [Cell or Molecular Dysfunction]
   833   C0008626:Abnormalities, Chromosomal [Disease or Syndrome]
   770   C0000768:Abnormalities [Congenital Abnormality]
   770   C0000769:abnormalities [Functional Concept]
   737 E C1704258:Abnormality [Finding]

Phrase: "with AML"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "or"

Phrase: "MDS."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]
Processing 00000000.tx.73: Patients were identified as having chromosome 5,7,17,or 16abnormalities by reviewing the karyotypes. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "as"

Phrase: "having"

Phrase: "chromosome 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008668:Chromosome 5 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "7,"

Phrase: "17,"

Phrase: "or"

Phrase: "16abnormalities by reviewing"

Phrase: "the karyotypes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022526:karyotypes [Laboratory Procedure]
  1000   C0178725:karyotypes [Laboratory or Test Result]
  1000   C1261273:Karyotypes [Organism Attribute]
Processing 00000000.tx.74: Each patient has 1or more cytogenetic changes and karyotypic abnormalities are not exclusive to these 4chromosomes. 

Phrase: "Each patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "has"

Phrase: "1or more cytogenetic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "karyotypic abnormalities"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0000768:Abnormalities [Congenital Abnormality]
   861   C0000769:abnormalities [Functional Concept]
   827 E C1704258:Abnormality [Finding]
   777 E C0205161:Abnormal [Qualitative Concept]
   777 E C2347472:% Abnormal [Quantitative Concept]
   777 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "are"

Phrase: "not exclusive to these 4chromosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1548966:Exclusive [Idea or Concept]
Processing 00000000.tx.75: The last bar includes only those patients with a 5q abnormality and inv(16) and no other 16abnormality. 

Phrase: "The last bar"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "those patients with a 5q abnormality"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "inv(16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021943:inv [Cell or Molecular Dysfunction]
   861   C1425144:INV [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "no other 16abnormality."
Processing 00000000.tx.76: On the basis of the correlations shown in Figure 1, we examined whether there was a critical target locus on chromosomes 5q, and whether the TP53 gene was indeed the target on 17p. 

Phrase: "On the basis of the correlations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707520:Correlation [Qualitative Concept]

Phrase: "shown in Figure 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "there"

Phrase: "was"

Phrase: "a critical target locus on chromosomes 5q,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "whether"

Phrase: "the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "was"

Phrase: "indeed"

Phrase: "the target on 17p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.77: Therefore, the results are presented below in 3distinct parts: (1) characterization of a putative critical locus at 5q13.3, (2) delineation of the target locus at 17p, and search for TP53 mutations, and (3) the sequence of genetic alterations in a case of secondary MDS with der(5;17). 

Phrase: "Therefore,"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "presented below"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0449450:Presented [Idea or Concept]
   799 E C0150312:Present [Quantitative Concept]

Phrase: "in 3distinct parts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449719:parts [Spatial Concept]
   861   C1709471:PARTS [Quantitative Concept]

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "characterization of a putative critical locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "at 5q13.3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521473:5q13 [Cell Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "delineation of the target locus"

Phrase: "at 17p,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "search for TP53 mutations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552603:search [Intellectual Product]
   770   C1706202:Search [Activity]

Phrase: "and ("

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "the sequence of genetic alterations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   781   C0596611:Sequence Alteration [Genetic Function]
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]

Phrase: "in a case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of secondary MDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026985:Myelodysplasia [Congenital Abnormality]
   861   C0026986:Myelodysplasia [Neoplastic Process]
   861   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "with der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")."
Processing 00000000.tx.78: Delineation of the critical 5q13.3 locus from patients with der(5;17) Two patients with unbalanced translocations between chromosomes 5q and 17p facilitated the search for the smallest region of loss on 5q. 

Phrase: "Delineation of the critical 5q13.3 locus"

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "Two patients with unbalanced translocations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "between chromosomes 5q"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C0796347:chromosome 5q [Nucleotide Sequence]
           5q
   861   C1521461:5q- [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "facilitated"

Phrase: "the search for the smallest region of loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1552603:search [Intellectual Product]
   744   C1706202:Search [Activity]

Phrase: "on 5q."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796347:5q [Nucleotide Sequence]
  1000   C1521461:5q- [Cell or Molecular Dysfunction]
Processing 00000000.tx.79: The der(5;17) in both patients resulted in deletions of 5q13.3 loci, but were in opposite orientations. 

Phrase: "The der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "in both patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "resulted in deletions of 5q13.3 loci,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C1521473:5q13 [Cell Component]
   748   C1880274:Deletions [Activity]
   714   C1274040:Result [Functional Concept]
   714 E C1442161:Deletion [Cell or Molecular Dysfunction]
   714 E C1511760:Deletion [Genetic Function]
   714   C1546471:Result [Idea or Concept]
   714   C1708726:Locus [Gene or Genome]
   714   C2825142:Result [Finding]

Phrase: "but"

Phrase: "were in opposite orientations."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0029266:Orientations [Mental Process]
   770   C1521805:Opposite [Spatial Concept]
   737 E C1704322:orientation [Spatial Concept]
   737 E C1704972:Orientation [Spatial Concept]
   737 E C3539923:Orientation [Intellectual Product]
Processing 00000000.tx.80: Patient 2,with de novo AML, retained heterozygosity for all the 5q31.1 loci and the distal 5q13.3 markers D5S2029, D5S620, and D5S626, yet showed a minimal deletion from 5q13.1-q13.3, which included the 5q13.3 markers AMFb347yf9 and D5S672 (Figure 2). 

Phrase: "Patient 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "with de novo AML,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   853   C0085669:Acute leukaemia [Neoplastic Process]
   853   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   840   C0023470:Myelogenous Leukemia [Neoplastic Process]
   804   C0023418:Leukaemia [Neoplastic Process]
   804   C0205178:acute [Temporal Concept]
   804   C0439677:Myelogenous [Qualitative Concept]

Phrase: "retained heterozygosity for all"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygosity [Organism Attribute]

Phrase: "the 5q31.1 loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1708726:Locus [Gene or Genome]
   734   C1521487:5q31.1 [Cell Component]

Phrase: "and"

Phrase: "the distal 5q13.3 markers D5S2029,"

Phrase: "D5S620,"

Phrase: "and"

Phrase: "D5S626,"

Phrase: "yet"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a minimal deletion from 5q13.1-q13.3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1442161:Deletion [Cell or Molecular Dysfunction]
   744   C1511760:Deletion [Genetic Function]
   744   C1880274:Deletion [Activity]

Phrase: "which"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the 5q13.3 markers AMFb347yf9"

Phrase: "and"

Phrase: "D5S672"

Phrase: "(Figure 2"

Phrase: ")."
Processing 00000000.tx.81: A similar patient with der(5;17) (patient 1) showed a deletion which apparently overlapped with that of patient 2.As shown in Figure 2B, the informativeness of the AFMb347yf9, D5S672, and D5S2029 loci in both these patients is revealed by the presence of 2major alleles in the normal sample. 

Phrase: "A similar patient with der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:*^patient [Patient or Disabled Group]

Phrase: ";17"

Phrase: ")"

Phrase: "(patient 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442161:Deletion [Cell or Molecular Dysfunction]
  1000   C1511760:Deletion [Genetic Function]
  1000   C1880274:Deletion [Activity]

Phrase: "which apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "overlapped with that of patient 2."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0185027:overlapped [Therapeutic or Preventive Procedure]
   719 E C1948020:Overlap [Conceptual Entity]

Phrase: "As"

Phrase: "shown in Figure 2B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450354:2b [Intellectual Product]
   770   C1706096:2B [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "the informativeness of the AFMb347yf9,"

Phrase: "D5S672,"

Phrase: "and"

Phrase: "D5S2029 loci in both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1708726:Locus [Gene or Genome]

Phrase: "these patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "is"

Phrase: "revealed by the presence of 2major alleles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002085:Alleles [Gene or Genome]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0443289:Revealed [Qualitative Concept]

Phrase: "in the normal sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.82: The leukemic cells of patient 1retains 2alleles of AFMb347yf9 and a single allele of both D5S672 and D5S2029 loci. 

Phrase: "The leukemic cells of patient 1retains 2alleles of AFMb347yf9"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C1517806:Leukemic Cell [Cell]
   745   C0007634:THE CELL [Cell]
           Cells
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "a single allele of both D5S672"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0002085:Allele [Gene or Genome]

Phrase: "and"

Phrase: "D5S2029 loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.83: Patient 2,however, retains 2alleles of D5S2029 and reveals allele loss for both D5S672 and AFMb347yf9. 

Phrase: "Patient 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "however,"

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "2alleles of D5S2029"

Phrase: "and"

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "allele loss for both D5S672"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   765   C0524869:Allelic Loss [Genetic Function]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "AFMb347yf9."
Processing 00000000.tx.84: In addition, the deletion pattern in patient 1confirms the revised order of markers, namely, centromere AFMb347yf9-D5S672-telomere. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the deletion pattern in patient 1confirms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "the revised order of markers,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1546524:Revised order [Intellectual Product]
   760   C1705175:Order [Intellectual Product]
   760   C1705176:Order [Qualitative Concept]
   760   C1705177:Order [Classification]
   760   C1705178:Order [Activity]
   760   C1882348:Order [Qualitative Concept]

Phrase: "namely,"

Phrase: "centromere AFMb347yf9-D5S672-telomere."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0085187:telomere [Cell Component]
Processing 00000000.tx.85: View larger version (2242K): [in this window] [in a new window]  Fig 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(2242K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.86: A. 

Phrase: "A."
Processing 00000000.tx.87: Delineation of the critical region of loss between in patients 1and 2. 

Phrase: "Delineation of the critical region of loss"

Phrase: "between"

Phrase: "in patients 1and 2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.88: Marker D5S2634 maps within 30-kb of marker D5S672 (SHGC radiation hybrid map) and is placed centromeric, based on results from our somatic cell hybrid. 

Phrase: "Marker D5S2634"

Phrase: "maps within 30-kb of marker D5S672"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0005516:Marker [Clinical Attribute]
   748   C0024779:Map [Manufactured Object]
   748   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1706473:Map [Conceptual Entity]

Phrase: "(SHGC radiation hybrid map"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   845   C1253949:Radiation Hybrid Map [Intellectual Product]
   818   C0887811:Radiation Hybrid [Cell]
   795   C0020205:Hybrid [Organism]
   795   C0024779:Map [Manufactured Object]
   795   C0034519:Radiation [Natural Phenomenon or Process]
   795   C0560559:Radiation [Quantitative Concept]
   795   C0851346:Radiation [Natural Phenomenon or Process]
   795   C1522449:Radiation [Therapeutic or Preventive Procedure]
   795   C1524020:Radiation [Therapeutic or Preventive Procedure]
   795   C1524021:Radiation [Research Activity]
   795   C1706473:Map [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "is"

Phrase: "placed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0442504:Place [Spatial Concept]
   966   C1704765:Place [Functional Concept]
   966   C1882509:Place [Activity]
   966   C3496241:place [Disease or Syndrome]

Phrase: "centromeric,"

Phrase: "based on results"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1527178:Based [Functional Concept]
   790   C1705938:Based [Idea or Concept]
   756 E C0002055:base [Inorganic Chemical]
   756 E C0178499:Base [Chemical Viewed Functionally]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756 E C1880279:Base [Biomedical or Dental Material]
   756   C2825142:Result [Finding]

Phrase: "from our somatic cell hybrid."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0020200:Somatic Cell Hybrid [Cell]
   901   C1257909:Somatic cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0020205:Hybrid [Organism]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C2986476:Somatic [Qualitative Concept]
   734 E C0599444:soma [Cell Component]
   734 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   721 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.89: The ordering of markers is supported by the YAC contig in Figure 3. 

Phrase: "The ordering of markers"

Phrase: "is"

Phrase: "supported by the YAC contig"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C0206665:Yeast Artificial Chromosome [Research Device]
   778   C0872017:Chromosome, Artificial [Research Device]
   748   C0008633:Chromosome [Cell Component]
   748   C0036025:yeast [Fungus]
   748   C0043392:Yeast [Food]
   748   C0043393:Yeast [Fungus]
   748   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   748   C1511491:Contig [Spatial Concept]
   748   C1521721:Supported [Conceptual Entity]
   748   C2004457:Artificial [Qualitative Concept]
   714 E C0183683:Support [Medical Device]

Phrase: "in Figure 3."
Processing 00000000.tx.90: B.

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.91: Loss of heterozygosity analysis of polymorphic markers at 5q13.3. 

Phrase: "Loss of heterozygosity analysis of polymorphic markers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1881449:Loss of Heterozygosity Analysis [Molecular Biology Research Technique]
   814   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   748   C1517945:Loss [Quantitative Concept]

Phrase: "at 5q13.3."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521473:5q13 [Cell Component]
Processing 00000000.tx.92: Paired samples of DNA from peripheral blood granulocytes or bone marrow blasts and mononuclear cells were PCR amplified for each of the 5q13.3 polymorphic markers. 

Phrase: "Paired samples of DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from peripheral blood granulocytes"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   901   C0229664:peripheral blood [Body Substance]
           Blood
   859 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0018183:Granulocytes [Cell]
   827   C0205100:Peripheral [Spatial Concept]
   827   C0857490:Granulocytes [Laboratory Procedure]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "bone marrow blasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0337026:blasts [Natural Phenomenon or Process]
   827   C0368761:Blasts [Cell]
   827   C0523113:Blasts [Laboratory Procedure]
   734   C0005953:Bone Marrow [Tissue]

Phrase: "and"

Phrase: "mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "amplified for each of the 5q13.3 polymorphic markers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1521473:5q13 [Cell Component]
   742   C1882417:Polymorphic [Qualitative Concept]
   708   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.93: Patient 1mononuclear cells were short term cultured to select for the leukemic population. 

Phrase: "Patient 1mononuclear cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "short term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0443303:Short-term [Temporal Concept]
   861   C1282927:short [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1806781:Short [Quantitative Concept]
   861   C2350002:Short [Quantitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "select for the leukemic population."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0032659:Population [Quantitative Concept]
   760   C1257890:Population [Population Group]
   760   C1707391:Select [Activity]
Processing 00000000.tx.94: The presence of 2alleles in the control sample rendered a given patient informative for the specific locus. 

Phrase: "The presence of 2alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the control sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "rendered"

Phrase: "a given patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "informative for the specific locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.95: N=normal sample. 

Phrase: "N=normal sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.96: L=leukemic sample. 

Phrase: "L=leukemic sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.97: Arrows mark the location of alleles. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the location of alleles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450429:Location [Spatial Concept]
   770   C1515974:Location [Body Location or Region]
Processing 00000000.tx.98: Stars indicate allele loss. 

Phrase: "Stars"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1825825:STARS [Gene or Genome]
   928 E C0995242:Stella [Bacterium]
   928 E C1426084:Stella [Gene or Genome]
   928 E C2986872:Stella [Gene or Genome]

Phrase: "indicate"

Phrase: "allele loss."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   958   C0524869:Allelic Loss [Genetic Function]
   861   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.99: Further refinement of the proximal limit of the 5q13.3 critical locus was facilitated by somatic cell hybrids, generated by fusing leukemic blasts of patient 1and LMTK murine fibroblasts. 

Phrase: "Further refinement of the proximal limit of the 5q13.3 critical locus"

Phrase: "was"

Phrase: "facilitated by somatic cell hybrids,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   862   C0020200:Somatic Cell Hybrids [Cell]
           Hybrid Cell
   806   C1257909:Somatic cell [Cell]
   781   C0007597:hybrid cell [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0020205:Hybrids [Organism]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2986476:Somatic [Qualitative Concept]
   751 E C0599444:Cell soma [Cell Component]
   751 E C2752549:cell soma [Cell Component]

Phrase: "generated by fusing leukemic blasts of patient 1and LMTK murine fibroblasts."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   756   C2697913:Leukemic Blasts [Laboratory Procedure]
   738   C0016030:Fibroblasts [Cell]
   738   C0026809:Murine [Mammal]
   738   C0030705:*^patient [Patient or Disabled Group]
   738   C0337026:blasts [Natural Phenomenon or Process]
   738   C0368761:Blasts [Cell]
   738   C0523113:Blasts [Laboratory Procedure]
   738   C0591833:Murine [Organic Chemical,Pharmacologic Substance]
   738   C0699952:fusing [Functional Concept]
   738   C3146294:Generated [Activity]
   704 E C1414861:FUSE [Gene or Genome]
   704 E C1708111:Fuse [Manufactured Object]
Processing 00000000.tx.100: A hybrid clone that contained the der(5;17) chromosome but not the normal chromosome 5was identified and characterized. 

Phrase: "A hybrid clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009013:Clone [Cell]
   861   C1522642:Clone [Tissue]
   789 E C1704387:Clonal [Qualitative Concept]
   761 E C0796368:clonality [Diagnostic Procedure]

Phrase: "that"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the normal chromosome 5was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.101: STS markers localized to this interval by the SHGC were tested against the hybrid by PCR amplification. 

Phrase: "STS markers"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   923   C0080145:Sequence Tagged Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C1519249:Sequence [Functional Concept]
   812   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   812   C1708632:Tagged [Qualitative Concept]
   812   C2825164:Site [Spatial Concept]
   779   C0005516:Marker [Clinical Attribute]
   779 E C0037293:Tag [Neoplastic Process]
   779 E C0181496:Tag [Manufactured Object]
   779 E C1710492:TAG [Gene or Genome]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "localized to this interval"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0392752:Localized [Spatial Concept]
   770   C1272706:Interval [Temporal Concept]
   770   C1552654:Interval [Idea or Concept]
   770   C1552713:Interval [Intellectual Product]

Phrase: "by the SHGC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]

Phrase: "were"

Phrase: "tested against the hybrid"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0020205:Hybrid [Organism]
   770   C0392366:tested [Intellectual Product]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "by PCR amplification."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.102: The der(5;17) chromosome contained markers AFMb347yf9 and D5S2634 but not D5S672. 

Phrase: "The der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "chromosome contained markers AFMb347yf9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0008631:Chromosome Markers [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "D5S2634"

Phrase: "but"

Phrase: "not D5S672."
Processing 00000000.tx.103: D5S2634, which is retained in the hybrid is within 30kb (less than 1cR) of D5S672, according to the SHGC radiation hybrid map. 

Phrase: "D5S2634,"

Phrase: "which"

Phrase: "is"

Phrase: "retained in the hybrid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020205:Hybrid [Organism]
   770   C0333118:Retained [Functional Concept]

Phrase: "is within 30kb"

Phrase: "(less than 1cR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0439092:Less Than [Intellectual Product]
           less
   790   C0547044:Less [Qualitative Concept]

Phrase: ")"

Phrase: "of D5S672,"

Phrase: "according to the SHGC radiation hybrid map."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   845   C1253949:Radiation Hybrid Map [Intellectual Product]
   818   C0887811:Radiation Hybrid [Cell]
   795   C0020205:Hybrid [Organism]
   795   C0024779:Map [Manufactured Object]
   795   C0034519:Radiation [Natural Phenomenon or Process]
   795   C0560559:Radiation [Quantitative Concept]
   795   C0851346:Radiation [Natural Phenomenon or Process]
   795   C1522449:Radiation [Therapeutic or Preventive Procedure]
   795   C1524020:Radiation [Therapeutic or Preventive Procedure]
   795   C1524021:Radiation [Research Activity]
   795   C1706473:Map [Conceptual Entity]
Processing 00000000.tx.104: Therefore, the proximal breakpoint in patient 1resides between the loci D5S672 and D5S2634 (Figure 2A). 

Phrase: "Therefore,"

Phrase: "the proximal breakpoint in patient 1resides"

Phrase: "between the loci D5S672"

Phrase: "and"

Phrase: "D5S2634"

Phrase: "(Figure 2A"

Phrase: ")."
Processing 00000000.tx.105: Lack of informativeness for the D5S1464 locus in patient 2diminishes finer definition of the telomeric limit of the critical region. 

Phrase: "Lack of informativeness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332268:lack [Qualitative Concept]

Phrase: "for the D5S1464 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "in patient 2diminishes finer definition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1550452:definition [Idea or Concept]
   812   C1704788:Definition [Conceptual Entity]
   812   C3539107:Definition [Intellectual Product]

Phrase: "of the telomeric limit"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0439801:limit [Functional Concept]
   861   C1549649:Limit [Idea or Concept]
   861   C2349209:Limit [Conceptual Entity]
   789 E C3542948:Limited [Intellectual Product]

Phrase: "of the critical region."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.106: Taken together, patients 1and 2delineate a critical region of loss between the D5S2634 and D5S2029 loci. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "patients 1and 2delineate"

Phrase: "a critical region of loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "between the D5S2634"

Phrase: "and"

Phrase: "D5S2029 loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.107: Generation of a YAC contig spanning the D5S1464-D5S641 interval To physically link the markers within the critical 5q13.3 region, we initiated a chromosomal walk from the telomeric end of this locus. 

Phrase: "Generation of a YAC contig"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "spanning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1711300:Span [Conceptual Entity]
   966   C2700613:Span [Quantitative Concept]

Phrase: "the D5S1464-D5S641 interval To physically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1272706:Interval [Temporal Concept]
   753   C1552654:Interval [Idea or Concept]
   753   C1552713:Interval [Intellectual Product]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "the markers within the critical 5q13.3 region,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0005516:Marker [Clinical Attribute]

Phrase: "we"

Phrase: "initiated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1548602:Initiate [Idea or Concept]
   966   C1704686:Initiate [Functional Concept]

Phrase: "a chromosomal walk from the telomeric end of this locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0080331:Walk [Daily or Recreational Activity]
Processing 00000000.tx.108: The YAC 944d6 served as the starting point and the end rescued fragment from the right arm tested positive by PCR for the YACs 965b11 and 934c2; 

Phrase: "The YAC 944d6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206665:Yeast Artificial Chromosome [Research Device]

Phrase: "served as the starting point"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]
   726   C0439659:Start [Temporal Concept]

Phrase: "and"

Phrase: "the end rescued fragment from the right arm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332255:fragment [Functional Concept]
   744   C1708096:Fragment [Qualitative Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "positive by PCR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]

Phrase: "for the YACs 965b11"

Phrase: "and"

Phrase: "934c2"

Phrase: ";"
Processing 00000000.tx.109: thus, orienting the D5S641, D5S2094, D5S1959, and GATA-P18104 loci telomeric of the D5S620 and D5S626 loci (Figure 3). 

Phrase: "thus,"

Phrase: "orienting"

Phrase: "the D5S641,"

Phrase: "D5S2094,"

Phrase: "D5S1959,"

Phrase: "and"

Phrase: "GATA-P18104 loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]

Phrase: "telomeric of the D5S620"

Phrase: "and"

Phrase: "D5S626 loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "(Figure 3"

Phrase: ")."
Processing 00000000.tx.110: Screening of the YACs 729f12, 765a5, 940d1, 934c2, and 744d10 with the additional markers yielded an order that is most consistent with centromere-D5S1464-(D5S2029/D5S806)-(D5S620/D5S626)-(D5S641/GATA-P18104)-telomere. 

Phrase: "Screening of the YACs 729f12,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220908:Screening [Health Care Activity]
   760   C0220909:screening [Functional Concept]
   760   C1698960:screening [Intellectual Product]
   760   C1710031:Screening [Diagnostic Procedure]
   760   C1710477:SCREENING [Research Activity]

Phrase: "765a5,"

Phrase: "940d1,"

Phrase: "934c2,"

Phrase: "and"

Phrase: "744d10 with the additional markers"

Phrase: "yielded"

Phrase: "an order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "most consistent with centromere-D5S1464-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(D5S2029/D5S806"

Phrase: ")"

Phrase: "-"

Phrase: "(D5S620/D5S626"

Phrase: ")"

Phrase: "-"

Phrase: "(D5S641/GATA-P18104"

Phrase: ")-"

Phrase: "telomere."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085187:telomere [Cell Component]
Processing 00000000.tx.111: View larger version (18K): [in this window] [in a new window]  Fig 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.112: Minimal tiling path of YACs between markers D5S1464 and GATAP-18104. 

Phrase: "Minimal tiling path of YACs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0919386:PATH [Laboratory Procedure]
   760   C1705483:Path [Intellectual Product]

Phrase: "between markers D5S1464"

Phrase: "and"

Phrase: "GATAP-18104."
Processing 00000000.tx.113: STS content of each YAC is indicated by vertical dotted lines. 

Phrase: "STS content of each YAC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0423896:Content [Mental Process]
   742   C0456205:Content [Conceptual Entity]

Phrase: "is"

Phrase: "indicated by vertical dotted lines."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205128:Vertical [Spatial Concept]
   760   C0205132:lines [Spatial Concept]
   760   C1444656:Indicated [Finding]
   726   C0872145:DOT [Therapeutic or Preventive Procedure]
   726 E C1550648:Line [Substance]
   726 E C1552960:Line [Quantitative Concept]
Processing 00000000.tx.114: The insert size of the YACs is shown in parentheses. 

Phrase: "The insert size of the YACs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456389:size [Spatial Concept]

Phrase: "is"

Phrase: "shown in parentheses."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.115: YACs in green hybridize to the der(5) chromosome and YACs in red hybridize to the der(3) chromosome. 

Phrase: "YACs in green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206665:YAC [Research Device]

Phrase: "hybridize to the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]

Phrase: "and"

Phrase: "YACs in red"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206665:YAC [Research Device]

Phrase: "hybridize to the der(3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "chromosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.116: 944d6R=end rescued fragment from the right arm of YAC 944d6. 

Phrase: "944d6R"

Phrase: "=end rescued fragment from the right arm of YAC 944d6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C0333708:Chromosome fragment [Cell or Molecular Dysfunction]
   736   C0332255:fragment [Functional Concept]
   736   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.117: 729f12L=end rescued fragment from the left arm of YAC 729f12. 

Phrase: "729f12L"

Phrase: "=end rescued fragment from the left arm of YAC 729f12."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   751   C0333708:Chromosome fragment [Cell or Molecular Dysfunction]
   736   C0332255:fragment [Functional Concept]
   736   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.118: Delineation of the 5q13.3 chromosomal breakpoint in the AML cell line, ML3 The AML cell line, ML3, has a der(3;5) and retains heterozygosity for most of the chromosome 5q loci. 

Phrase: "Delineation of the 5q13.3 chromosomal breakpoint"

Phrase: "in the AML cell line,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1517806:Leukemic Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   717   C0023467:Acute myelogenous leukaemia [Neoplastic Process]

Phrase: "ML3"

Phrase: "The AML cell line,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   840   C0007600:Cell Line [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:Line [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1517806:Leukemic Cell [Cell]
   804   C1550648:Line [Substance]
   804   C1552960:Line [Quantitative Concept]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   717   C0023467:Acute myelogenous leukaemia [Neoplastic Process]

Phrase: "ML3,"

Phrase: "has"

Phrase: "a der(3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "heterozygosity for most of the chromosome 5q loci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0019425:Heterozygosity [Organism Attribute]
Processing 00000000.tx.119: The translocation disrupts the 5q13.3 region and so facilitated further delineation of the critical region. 

Phrase: "The translocation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040715:Translocation [Cell or Molecular Dysfunction]
  1000   C2987521:Translocation [Activity]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the 5q13.3 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "facilitated"

Phrase: "further delineation of the critical region."
Processing 00000000.tx.120: Inter-alu PCR products from 5q13.3 YACs (Figure 3) were used as FISH probes on metaphases from these cells. 

Phrase: "Inter-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205103:Inter- [Spatial Concept]
  1000   C1548610:Inter [Temporal Concept]

Phrase: "alu PCR products from 5q13.3 YACs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1514468:Products [Entity]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "(Figure 3"

Phrase: ")"

Phrase: "were"

Phrase: "used as FISH"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   882   C0162789:Fluorescent in Situ Hybridization [Molecular Biology Research Technique]
           fluorescent hybridization situ
   833   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   790   C0444498:In situ [Spatial Concept]
   753   C0020202:Hybridisation [Genetic Function]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1273517:used [Finding]
   753   C1300517:Hybridization [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "probes on metaphases"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0182400:Probe [Medical Device]
   790   C1621812:Metaphases [Cell Function]
   790   C1704681:Probe [Gene or Genome]
   790   C2347609:Probe [Chemical Viewed Functionally]
   790   C3536729:Probe [Manufactured Object]
   756 E C0025564:Metaphase [Cell Function]

Phrase: "from these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.121: YACs 745a9, containing the marker AFMb347yf9, hybridized to the der(5) and YAC 965b11, containing markers D5S620 and D5S626, hybridized to the der(3).1 YACs 848c4 and 765a5, containing markers D5S672 and D5S1464 respectively, hybridized to the telomeric end of the der(5) chromosome. 

Phrase: "YACs 745a9,"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the marker AFMb347yf9,"

Phrase: "hybridized to the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "and"

Phrase: "YAC 965b11,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206665:Yeast Artificial Chromosome [Research Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "markers D5S620"

Phrase: "and"

Phrase: "D5S626,"

Phrase: "hybridized to the der(3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ").1 YACs 848c4"

Phrase: "and"

Phrase: "765a5,"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "markers D5S672"

Phrase: "and"

Phrase: "D5S1464 respectively,"

Phrase: "hybridized to the telomeric end of the der(5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0444930:End [Spatial Concept]
   742   C1511780:der [Cell or Molecular Dysfunction]
   742   C2746065:End [Temporal Concept]

Phrase: ")"

Phrase: "chromosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.122: YAC 940d1, containing the markers D5S1464 as well as D5S620, also hybridized to the der(5) chromosome. 

Phrase: "YAC 940d1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206665:Yeast Artificial Chromosome [Research Device]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the markers D5S1464"

Phrase: "as well as"

Phrase: "D5S620,"

Phrase: "also"

Phrase: "hybridized to the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "chromosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.123: YAC932c2, with markers D5S2029/D5S806 and D5S620/D5S626 hybridized to the der (3) chromosome. 

Phrase: "YAC932c2,"

Phrase: "with markers D5S2029/D5S806"

Phrase: "and"

Phrase: "D5S620/D5S626"

Phrase: "hybridized to the der (3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "chromosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.124: Figure 3 demonstrates that the 5q13.3 locus disrupted in the ML3 cell line resides between D5S1464 and D5S620/D5S626, a breakpoint at the telomeric end of the critical region of loss (Figure 2). 

Phrase: "Figure 3"

Phrase: "demonstrates"

Phrase: "that"

Phrase: "the 5q13.3 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "disrupted in the ML3 cell line"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:Line [Spatial Concept]
   753   C0332454:Disrupted [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "resides between D5S1464"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2982691:Reside [Activity]

Phrase: "and"

Phrase: "D5S620/D5S626,"

Phrase: "a breakpoint at the telomeric end of the critical region of loss"

Phrase: "(Figure 2"

Phrase: ")."
Processing 00000000.tx.125: Absence of a split signal between the der (5) and der (3) chromosomes with either YAC 934c2 or YAC 940d1 could be due to the small region of overlap between the 2YACs that may represent less than 20% of the insert in either case. 

Phrase: "Absence of a split signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "between the der (5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "and"

Phrase: "der (3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ")"

Phrase: "chromosomes with either YAC 934c2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0206665:Chromosomes, Artificial, Yeast [Research Device]
   774   C0872017:Chromosomes, Artificial [Research Device]
   748   C0008633:Chromosomes [Cell Component]

Phrase: "or"

Phrase: "YAC 940d1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206665:Yeast Artificial Chromosome [Research Device]

Phrase: "could"

Phrase: "be due to the small region of overlap"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0017446:Region [Geographic Area]
   744   C0185027:overlap [Therapeutic or Preventive Procedure]
   744   C0205147:Region [Spatial Concept]
   744   C0700321:Small [Quantitative Concept]
   744   C1948020:Overlap [Conceptual Entity]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "between the 2YACs"

Phrase: "that"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "less than 20% of the insert"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0441587:Insert [Health Care Activity]
   753   C0547044:Less [Qualitative Concept]
   753   C1743766:Insert [Medical Device]
   753   C1883719:Insert [Functional Concept]

Phrase: "in either case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.126: The TP53 gene is deleted in patients with 5q13.3 translocations and deletions Microsatellite analysis was used to determine whether patients who show allele loss for 5q loci and anomalies of chromosome 17p also show a region of loss that included the TP53 gene. 

Phrase: "The TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "deleted in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1880274:Deleted [Activity]

Phrase: "with 5q13.3 translocations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0040715:Translocations [Cell or Molecular Dysfunction]
   793 E C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "deletions Microsatellite analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1519302:Microsatellite [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "who"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "allele loss for 5q loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   765   C0524869:Allelic Loss [Genetic Function]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "anomalies of chromosome 17p also"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   851   C0008626:Anomaly of chromosome [Disease or Syndrome]
           anomalies chromosome
   797   C0008625:Chromosome Anomalies [Cell or Molecular Dysfunction]
   760   C0000769:anomalies [Functional Concept]
   726 E C1704258:Anomaly [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a region of loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Region [Geographic Area]
   770   C0205147:Region [Spatial Concept]

Phrase: "that"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the TP53 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.127: Two pairs of markers that are centromeric (D17S954 and D17S786) and telomeric (D17S938 and D17S796) of the TP53 gene were selected. 

Phrase: "Two pairs of markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709450:Pair [Qualitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "centromeric"

Phrase: "(D17S954"

Phrase: "and"

Phrase: "D17S786"

Phrase: ")"

Phrase: "and"

Phrase: "telomeric"

Phrase: "(D17S938"

Phrase: "and"

Phrase: "D17S796"

Phrase: ")"

Phrase: "of the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "selected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]
Processing 00000000.tx.128: The microsatellite marker D17S1353 maps within the same YAC 728b11 as the TP53 gene, but its orientation with respect to the TP53 gene is unclear. 

Phrase: "The microsatellite marker D17S1353"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1519302:Microsatellite Marker [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "maps within the same YAC 728b11"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0206665:Yeast Artificial Chromosome [Research Device]
   770   C0872017:Chromosome, Artificial [Research Device]
   767   C0814036:chromosome map [Intellectual Product]
   744   C0008633:Chromosome [Cell Component]
   744   C0024779:Map [Manufactured Object]
   744   C0026045:MAPs [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0036025:yeast [Fungus]
   744   C0043392:Yeast [Food]
   744   C0043393:Yeast [Fungus]
   744   C0445247:Same [Qualitative Concept]
   744   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   744   C1706473:Map [Conceptual Entity]
   744   C2004457:Artificial [Qualitative Concept]

Phrase: "as the TP53 gene,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "but"

Phrase: "its orientation with respect to the TP53 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0029266:Orientation [Mental Process]
   744   C1704322:orientation [Spatial Concept]
   744   C1704972:Orientation [Spatial Concept]
   744   C3539923:Orientation [Intellectual Product]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.129: In total, 15patients with chromosome 5deletions, including 2patients whose interstitial deletions were entirely telomeric of the 5q13.3 locus, were analyzed. 

Phrase: "In total,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: "15patients with chromosome 5deletions,"

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "2patients"

Phrase: "whose interstitial deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "were"

Phrase: "entirely telomeric of the 5q13.3 locus,"

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.130: Surprisingly, we found that the 4patients who had allele loss for 17p loci had the 5q13.3 deletion in common (ie, contiguous loss of loci within the D5S672-D5S626 interval). 

Phrase: "Surprisingly,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the 4patients"

Phrase: "who"

Phrase: "had"

Phrase: "allele loss for 17p loci"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   765   C0524869:Allelic Loss [Genetic Function]
   760   C1517945:Loss [Quantitative Concept]

Phrase: "had"

Phrase: "the 5q13.3 deletion in common"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "("

Phrase: "ie"

Phrase: ","

Phrase: "contiguous loss of loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "within the D5S672-D5S626 interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1272706:Interval [Temporal Concept]
   827   C1552654:Interval [Idea or Concept]
   827   C1552713:Interval [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.131: The karyotypes and diagnoses of these 4patients are shown in Table 1.  

Phrase: "The karyotypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022526:karyotypes [Laboratory Procedure]
  1000   C0178725:karyotypes [Laboratory or Test Result]
  1000   C1261273:Karyotypes [Organism Attribute]

Phrase: "and"

Phrase: "diagnoses of these 4patients"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0011900:Diagnoses [Finding]
   737 E C1704338:diagnosis [Qualitative Concept]
   737 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "are"

Phrase: "shown in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.132: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.133: Characteristics of patients with loss of heterozygosity for 5q13.3 loci Patients 1,3,and 4have deletions, including markers that flank the TP53 gene. 

Phrase: "Characteristics of patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   841   C0815172:patient characteristics [Clinical Attribute]
   790   C1521970:Characteristics [Qualitative Concept]

Phrase: "with loss of heterozygosity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0524869:Loss of Heterozygosity [Genetic Function]
   812   C0019425:Heterozygosity [Organism Attribute]
   812   C0332287:With [Qualitative Concept]
   812   C1517945:Loss [Quantitative Concept]
   812   C1705690:With [Intellectual Product]

Phrase: "for 5q13.3 loci Patients 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C1521475:5q13.1 [Cell Component]
   804   C0030705:Patients [Patient or Disabled Group]
   804   C1521473:5q13 [Cell Component]
   771   C1708726:Locus [Gene or Genome]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "4have deletions,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "that"

Phrase: "flank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:Flank [Body Location or Region]

Phrase: "the TP53 gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.134: Patient 2has a telomeric deletion that includes markers up to the TP53 region, but because there is a lack of polymorphic markers in this region, a more a precise breakpoint could not be achieved. 

Phrase: "Patient 2has"

Phrase: "a telomeric deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "markers up to the TP53 region,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0005516:Marker [Clinical Attribute]

Phrase: "but"

Phrase: "because"

Phrase: "there"

Phrase: "is"

Phrase: "a lack of polymorphic markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "in this region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "a precise breakpoint"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "achieved."
Processing 00000000.tx.135: The TP53 mutation analysis, however, suggests that patient 2carried only 1copy of TP53 (see below). 

Phrase: "The TP53 mutation analysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0796357:mutation analysis [Laboratory Procedure]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "however,"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that patient 2carried only 1copy of TP53"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.136: Interestingly, patient 4who did not show any cytogenetic anomaly of chromosome 17appears to have harbored a small deletion (Figure 4). 

Phrase: "Interestingly,"

Phrase: "patient 4who"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "any cytogenetic anomaly of chromosome 17appears to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0008626:Anomaly of chromosome [Disease or Syndrome]
           Chromosome anomaly NOS
   748   C1704258:Anomaly [Finding]

Phrase: "have"

Phrase: "harbored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "a small deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: "(Figure 4"

Phrase: ")."
Processing 00000000.tx.137: View larger version (1830K): [in this window] [in a new window]  Fig 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(1830K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.138: A. 

Phrase: "A."
Processing 00000000.tx.139: The ordering of markers within the region is based on published mapping data from the SHGC. 

Phrase: "The ordering of markers"

Phrase: "within the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "is"

Phrase: "based on published mapping data"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0034037:Published [Occupational Activity]
   760   C1283195:Mapping [Activity]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1704324:Published [Intellectual Product]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0024779:Map [Manufactured Object]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1706473:Map [Conceptual Entity]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "from the SHGC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205099:Center [Spatial Concept]
Processing 00000000.tx.140: Distances in centirays (cR) are from the p-arm telomere as determined by the SHGC. 

Phrase: "Distances in centirays (cR)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0012751:distances [Quantitative Concept]
   706 E C0443203:Distant [Spatial Concept]

Phrase: "are from the p-arm telomere"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0085187:telomere [Cell Component]
   753   C0446516:Arm [Body Location or Region]
   753   C1269078:Arm [Body Part, Organ, or Organ Component]
   753   C1269612:Arm [Body Location or Region]
   753   C1551058:Are [Quantitative Concept]

Phrase: "as"

Phrase: "determined by the SHGC."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0017429:Genome, Human [Gene or Genome]
   748   C0017428:Genome [Gene or Genome]
   748   C0086418:Human [Human]
   748   C0205099:Center [Spatial Concept]
   748   C2338314:Genome [Conceptual Entity]
Processing 00000000.tx.141: B.

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.142: Loss of heterozygosity analysis of polymorphic markers at 17p13. 

Phrase: "Loss of heterozygosity analysis of polymorphic markers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1881449:Loss of Heterozygosity Analysis [Molecular Biology Research Technique]
   814   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   748   C1517945:Loss [Quantitative Concept]

Phrase: "at 17p13."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1520749:17p13 [Cell Component]
Processing 00000000.tx.143: Paired samples of DNA from peripheral blood granulocytes or bone marrow blasts and mononuclear cells were PCR amplified for each of the 17p13 polymorphic markers. 

Phrase: "Paired samples of DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0370003:Sample [Substance]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "from peripheral blood granulocytes"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   901   C0229664:peripheral blood [Body Substance]
           Blood
   859 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0018183:Granulocytes [Cell]
   827   C0205100:Peripheral [Spatial Concept]
   827   C0857490:Granulocytes [Laboratory Procedure]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "or"

Phrase: "bone marrow blasts"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0337026:blasts [Natural Phenomenon or Process]
   827   C0368761:Blasts [Cell]
   827   C0523113:Blasts [Laboratory Procedure]
   734   C0005953:Bone Marrow [Tissue]

Phrase: "and"

Phrase: "mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "amplified for each of the 17p13 polymorphic markers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1520749:17p13 [Cell Component]
   744   C1882417:Polymorphic [Qualitative Concept]
   711   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.144: The presence of 2alleles in the mononuclear cells rendered a given patient informative for the specific locus. 

Phrase: "The presence of 2alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the mononuclear cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0806987:Mononuclear cells [Cell]
   861   C0007634:Cells [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "rendered"

Phrase: "a given patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "informative for the specific locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.145: LOH=loss of heterozygosity. 

Phrase: "LOH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   790   C1517945:Loss [Quantitative Concept]

Phrase: "=loss of heterozygosity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   790   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.146: N=normal sample. 

Phrase: "N=normal sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.147: L=leukemic sample. 

Phrase: "L=leukemic sample."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.148: Arrows mark the location of alleles. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "mark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]

Phrase: "the location of alleles."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450429:Location [Spatial Concept]
   770   C1515974:Location [Body Location or Region]
Processing 00000000.tx.149: Stars indicate allele loss. 

Phrase: "Stars"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1825825:STARS [Gene or Genome]
   928 E C0995242:Stella [Bacterium]
   928 E C1426084:Stella [Gene or Genome]
   928 E C2986872:Stella [Gene or Genome]

Phrase: "indicate"

Phrase: "allele loss."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   958   C0524869:Allelic Loss [Genetic Function]
   861   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.150: TP53 gene is mutated in patients with allele loss for 17p and the cell line, ML3 To determine whether the remaining allele of the TP53 gene was mutated, we sequenced exons 4through 8in 15patients with 5q deletions. 

Phrase: "TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "mutated in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]

Phrase: "with allele loss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   958   C0524869:Allelic Loss [Genetic Function]
   861   C1517945:Loss [Quantitative Concept]

Phrase: "for 17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the cell line,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0007600:Cell Line [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:Line [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "ML3 To"

Phrase: "determine"

Phrase: "whether"

Phrase: "the remaining allele of the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0002085:Allele [Gene or Genome]
           allelic gene

Phrase: "was"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "exons 4through 8in 15patients with 5q deletions."
Processing 00000000.tx.151: As expected, all 4patients with LOH for 5q13.3 and 17p loci also had a mutation of the remaining TP53 allele (Figure 5A). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "all 4patients with LOH"

Phrase: "for 5q13.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521473:5q13 [Cell Component]

Phrase: "and"

Phrase: "17p loci also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708726:Locus [Gene or Genome]

Phrase: "had"

Phrase: "a mutation of the remaining TP53 allele"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Figure 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.152: Patients 1and 3had the common TP53 mutations, R175H and R273H, respectively; 

Phrase: "Patients 1and 3had"

Phrase: "the common TP53 mutations,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "R175H"

Phrase: "and"

Phrase: "R273H,"

Phrase: "respectively"

Phrase: ";"
Processing 00000000.tx.153: whereas, patients 2and 4had more rare mutations Y220S and E294*, respectively. 

Phrase: "whereas"

Phrase: ","

Phrase: "patients 2and 4had more rare mutations Y220S"

Phrase: "and"

Phrase: "E294"

Phrase: "*,"

Phrase: "respectively."
Processing 00000000.tx.154: Although the ML3 cells do not appear to have chromosome 17abnormalities by G-banding (JC Liang, unpublished results), we tested for TP53 mutation given the 5q13.3 abnormality. 

Phrase: "Although"

Phrase: "the ML3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "chromosome 17abnormalities by G-banding"

Phrase: "(JC Liang,"

Phrase: "unpublished results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "tested for TP53 mutation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0026882:Mutation [Genetic Function]
   770   C0392366:tested [Intellectual Product]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the 5q13.3 abnormality."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1704258:Abnormality [Finding]
   755 E C0205161:Abnormal [Qualitative Concept]
   755 E C2347472:% Abnormal [Quantitative Concept]
   755 E C2699333:ABNORMAL [Intellectual Product]
Processing 00000000.tx.155: ML3 cells have a mutation R248Q, which has been reported in solid tumors and Li Fraumeni Syndrome families.21 Patient 2,for whom LOH for the TP53 gene could not be verified, shows only residual evidence of the normal TP53 allele. 

Phrase: "ML3 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "a mutation R248Q,"

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "reported in solid tumors"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   833   C0280100:solid tumors [Neoplastic Process]
   770   C0027651:Tumors [Neoplastic Process]
   770   C0205208:Solid [Qualitative Concept]
   770   C0302909:Solid [Substance]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1378566:Solid [Biomedical or Dental Material]
   770   C3496591:Reported [Clinical Attribute]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C3273238:Report [Intellectual Product]
   737 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "Li Fraumeni Syndrome families.21 Patient 2,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   911   C1836482:Li-Fraumeni Syndrome 2 [Disease or Syndrome]
   845   C0079419:Li-Fraumeni syndrome [Gene or Genome]
   845   C0085390:Li-Fraumeni Syndrome [Neoplastic Process]
   795   C0015576:Families [Family Group]
   795   C0030705:*^patient [Patient or Disabled Group]
   795   C0039082:Syndrome [Disease or Syndrome]
   795   C1704727:Family [Conceptual Entity]
   795   C3495095:Li+ [Element, Ion, or Isotope]
   712 E C0241888:Familial [Functional Concept]

Phrase: "for whom LOH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0524869:Loss of Heterozygosity [Genetic Function]
   804   C0019425:Heterozygosity [Organism Attribute]
   804   C0521125:For [Qualitative Concept]
   804   C1517945:Loss [Quantitative Concept]

Phrase: "for the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "verified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verified [Functional Concept]

Phrase: ","

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "only residual evidence of the normal TP53 allele."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.156: For patient 3and ML3, no normal allele could be detected by sequencing (Figure 5B). 

Phrase: "For patient 3and ML3,"

Phrase: "no normal allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "could"

Phrase: "be"

Phrase: "detected by sequencing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
   790   C1553778:Sequencing [Intellectual Product]
   790   C1561491:Sequencing [Functional Concept]

Phrase: "(Figure 5B"

Phrase: ")."
Processing 00000000.tx.157: View larger version (41K): [in this window] [in a new window]  Fig 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.158: A. 

Phrase: "A."
Processing 00000000.tx.159: Mutations in remaining allele of TP53. 

Phrase: "Mutations in remaining allele of TP53."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.160: Exons 4through 8of the TP53 gene were amplified by PCR using intronic primers and sequenced to identify mutations. 

Phrase: "Exons 4through 8of"

Phrase: "the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "were"

Phrase: "amplified by PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0337112:Chain [Manufactured Object]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1524075:Chain [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "intronic primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.161: Patients 1,2,3,4,and ML3 each had a mutation in the coding region of the gene. 

Phrase: "Patients 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "and"

Phrase: "ML3"

Phrase: "each"

Phrase: "had"

Phrase: "a mutation in the coding region of the gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0596611:Gene Mutation [Genetic Function]
   742   C0026882:Mutation [Genetic Function]
   742   C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.162: B.

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.163: Histograms of mutant TP53 alleles from patients. 

Phrase: "Histograms of mutant TP53 alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2348974:Histogram [Manufactured Object]

Phrase: "from patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.164: Point mutations are designated by arrows. 

Phrase: "Point mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0162735:Point Mutations [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "designated by arrows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0336721:arrows [Manufactured Object]
   790   C1524084:Designated [Functional Concept]
Processing 00000000.tx.165: The der(5;17) precedes mutation of TP53 that is involved in leukemic progression Patient 1presented with secondary MDS within 3years after therapy for her primary malignancy of acute promyelocytic leukemia (APL). 

Phrase: "The der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "precedes"

Phrase: "mutation of TP53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "is"

Phrase: "involved in leukemic progression Patient 1presented"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0030705:*^patient [Patient or Disabled Group]
   753   C0242656:progression [Pathologic Function]
   753   C0449258:Progression [Functional Concept]
   753   C1314939:Involved [Functional Concept]

Phrase: "with secondary MDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026985:Myelodysplasia [Congenital Abnormality]
   861   C0026986:Myelodysplasia [Neoplastic Process]
   861   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "within 3years"

Phrase: "after therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "for her primary malignancy"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0006826:Malignancy [Neoplastic Process]
   861   C1306459:Malignancy [Finding]
   789 E C0205282:Malignant [Qualitative Concept]
   789 E C0334590:MALIGNANT [Neoplastic Process]
   789 E C1533592:MALIGNANT [Neoplastic Process]

Phrase: "of acute promyelocytic leukemia (APL)."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0023487:Acute Promyelocytic Leukemia [Neoplastic Process]
           Promyelocytic Leukemia
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C1366903:promyelocytic leukemia [Gene or Genome]
   901   C2745900:Promyelocytic leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
Processing 00000000.tx.166: As part of the follow-up, several routine cytogenetic studies were performed. 

Phrase: "As part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the follow-up, several routine cytogenetic studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   904   C0016441:Follow-Up Studies [Research Activity]
   827   C0200896:Cytogenetic Studies [Laboratory Procedure]
   799   C0010802:Cytogenetic [Biomedical Occupation or Discipline]
   799   C0947630:studies [Laboratory Procedure]
   766 E C0557651:Study [Manufactured Object]
   766 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.167: An abnormal clone with -5,add(17p11.2) as the sole abnormality was first identified 29months after her therapy. 

Phrase: "An abnormal clone with -5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0009013:Clone [Cell]
   760   C1522642:Clone [Tissue]

Phrase: "add(17p11.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0947272:Add 2 [Quantitative Concept]
   901   C1520746:17p11.2 [Cell Component]
   827   C1883712:Add [Functional Concept]

Phrase: ")"

Phrase: "as the sole abnormality"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1704258:Abnormality [Finding]
   789 E C0205161:Abnormal [Qualitative Concept]
   789 E C2347472:% Abnormal [Quantitative Concept]
   789 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "was"

Phrase: "first identified 29months after her therapy."
Processing 00000000.tx.168: Retrospective FISH analysis on serial bone marrow samples revealed that the -5,add(17p) was actually a der(5;17). 

Phrase: "Retrospective FISH analysis on serial bone marrow samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]
   737   C1303103:Sample analysis [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the -5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "add(17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0796349:17p [Nucleotide Sequence]
   861   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "was"

Phrase: "actually"

Phrase: "a der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")."
Processing 00000000.tx.169: Metaphase FISH also showed that the der(5;17) clone expanded over the previous 8months (Table 2).  

Phrase: "Metaphase FISH also"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0162789:Fluorescent in Situ Hybridization [Molecular Biology Research Technique]
   861   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]
           situ hybridization
   827   C0444498:In situ [Spatial Concept]
   799   C0020202:Hybridisation [Genetic Function]
   799   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C1300517:Hybridization [Laboratory Procedure]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "expanded over the previous 8months"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205156:Previous [Temporal Concept]
   760   C0205229:expanded [Spatial Concept]
   760   C1552607:previous [Temporal Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.171: Progression of myelodysplasia patient 1 We used fixed cells from serial samples to determine the stage at which the mutation in the TP53 gene occurred. 

Phrase: "Progression of myelodysplasia patient 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0242656:progression [Pathologic Function]
   760   C0449258:Progression [Functional Concept]

Phrase: "We"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fixed cells from serial samples to"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C1253961:Fixed cell [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "determine"

Phrase: "the stage at which"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205390:Stage [Temporal Concept]
   770   C1300072:Stage [Clinical Attribute]
   770   C1306673:Stage [Qualitative Concept]

Phrase: "the mutation in the TP53 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurred."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.172: The first sign of mutation was seen 32months after the APL diagnosis, suggesting that the mutation occurred in the der(5;17) clone. 

Phrase: "The first sign of mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0449990:First sign [Intellectual Product]
   760   C0311392:Sign [Finding]
   760   C1547188:Sign [Idea or Concept]

Phrase: "was"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "32months after the APL diagnosis,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurred in the der(5"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1511780:der [Cell or Molecular Dysfunction]
   760   C1709305:Occurred [Activity]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: ";17"

Phrase: ")"

Phrase: "clone."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]
Processing 00000000.tx.173: Consistent with a TP53 inactivation mutation, numerous cytogenetic changes characteristic of genomic instability, were seen at 35months (Table 2).  

Phrase: "Consistent with a TP53 inactivation mutation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "numerous cytogenetic changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "characteristic of genomic instability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "were"

Phrase: "seen at 35months"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.174: Discussion Top Abstract Introduction Materials and methods Results Discussion References This study is a combinatorial analyses of 2distinct cytogenetic alterations, namely, deletions of 5q and 17p. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "a combinatorial analyses of 2distinct cytogenetic alterations,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0752095:Cytogenetic Analyses [Molecular Biology Research Technique]
   714   C0002778:Analysis [Laboratory Procedure]
   714   C0936012:Analysis [Research Activity]
   714   C1524024:analysis [Functional Concept]

Phrase: "namely,"

Phrase: "deletions of 5q"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   790   C1880274:Deletions [Activity]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "17p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]
Processing 00000000.tx.175: The investigations allow us to conclude that unbalanced translocations between chromosomes 5and 17target a critical locus at 5q13.3 and the TP53 gene (patients 1and 2). 

Phrase: "The investigations"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1261322:Investigations [Health Care Activity]
   966 E C1552578:investigation [Idea or Concept]
   916 E C1517586:Investigational [Qualitative Concept]
   916 E C3245491:investigational [Intellectual Product]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that unbalanced translocations between chromosomes 5and 17target"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   762   C1519758:Unbalanced Translocation [Cell or Molecular Dysfunction]
   757   C0040715:chromosome translocations [Cell or Molecular Dysfunction]
           Translocations
   714 E C2987521:Translocation [Activity]

Phrase: "a critical locus at 5q13.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "(patients 1and 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: ")."
Processing 00000000.tx.176: Both of these loci may also be deleted by separate events as seen in ML3 and patients 3and 4. 

Phrase: "Both of these loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   737   C1708726:Locus [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "deleted by separate events"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441471:Events [Event]
   770   C0443299:Separate [Spatial Concept]
   770   C1880274:Deleted [Activity]
   770   C3541888:Events [Classification]

Phrase: "as"

Phrase: "seen in ML3"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "and"

Phrase: "patients 3and 4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.177: Cosegregation of deletions of chromosomes 5and 17 The evidence provided in this report and that of Soenen et al12 suggests that unbalanced chromosomal translocations may be a common mechanism that hematopoietic cells use to cause the physical loss of the TP53 gene. 

Phrase: "Cosegregation of deletions of chromosomes 5and 17"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2986591:Cosegregation [Functional Concept]

Phrase: "The evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "provided in this report"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C1999230:Provided [Activity]
   770   C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "that of Soenen et al12"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that unbalanced chromosomal translocations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0040715:CHROMOSOMAL TRANSLOCATIONS [Cell or Molecular Dysfunction]
           Translocations
   896   C1519758:Unbalanced Translocation [Cell or Molecular Dysfunction]
   827   C0008633:Chromosomal [Cell Component]
   793 E C2987521:Translocation [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "a common mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "that hematopoietic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C2323499:Hematopoietic cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "the physical loss of the TP53 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.178: There is a strong indication for cosegregation of loss of chromosome 5and 17sequences (Figure 1). 

Phrase: "There"

Phrase: "is"

Phrase: "a strong indication for cosegregation of loss of chromosome 5and 17sequences"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392360:indication [Idea or Concept]
   738   C3146298:Indication [Functional Concept]

Phrase: "(Figure 1"

Phrase: ")."
Processing 00000000.tx.179: The higher frequency of chromosome 5deletions than 17p deletions suggests it being an earlier genetic lesion. 

Phrase: "The higher frequency of chromosome 5deletions"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   773   C0205212:High frequency [Temporal Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "than 17p deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1880274:Deletions [Activity]
   827 E C1442161:Deletion [Cell or Molecular Dysfunction]
   827 E C1511760:Deletion [Genetic Function]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "it"

Phrase: "being"

Phrase: "an earlier genetic lesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   859   C0744369:Genital Lesion [Finding]
   827   C0221198:Lesion [Finding]
   827   C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.180: Inversely, 65% (134/205) of those patients with loss of 17p sequences also have deletions of chromosome 5,which is consistent with data reported by others.12,13 Deletions of chromosome 5occur in a broad range of clonal myeloid anomalies An eclectic group that includes the indolent, transfusion-dependant refractory anemia (RA), the highly refractory and aggressive RAEB-t, and AML harbor large deletions of chromosome 5.

Phrase: "Inversely,"

Phrase: "65%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "(134/205"

Phrase: ")"

Phrase: "of those patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "of 17p"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0796349:17p [Nucleotide Sequence]
  1000   C1553586:17p [Body Part, Organ, or Organ Component]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "also"

Phrase: "have"

Phrase: "deletions of chromosome 5,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   898   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with data"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "reported by others.12,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1709908:Reported By [Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1955473:Others [Finding]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "13 Deletions of chromosome 5occur"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   851   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   760   C1880274:Deletions [Activity]
   726 E C1442161:Deletion [Cell or Molecular Dysfunction]
   726 E C1511760:Deletion [Genetic Function]

Phrase: "in a broad range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1514721:Range [Quantitative Concept]
   861   C2348147:Range [Quantitative Concept]
   861   C3542016:Range [Intellectual Product]

Phrase: "of clonal myeloid anomalies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0000769:anomalies [Functional Concept]
   793 E C1704258:Anomaly [Finding]
   743 E C3277934:Anomalous [Finding]

Phrase: "An eclectic group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the indolent, transfusion-dependant refractory anemia (RA),"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0002893:Anemia, Refractory [Disease or Syndrome]
   840   C2981142:Refractory anaemia [Disease or Syndrome]
   804   C0002871:Anaemia [Disease or Syndrome]
   804   C0205269:Refractory [Functional Concept]
   804   C1000483:Anemia [Plant]
   733 E C0857322:anaemic [Finding]

Phrase: "the highly refractory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205269:Refractory [Functional Concept]

Phrase: "and"

Phrase: "aggressive RAEB-t,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0280028:RAEB-T [Disease or Syndrome]
   827   C0002894:RAEB [Neoplastic Process]

Phrase: "and"

Phrase: "AML harbor large deletions of chromosome 5."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   779   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Deletions, Chromosome
   742   C1880274:Deletions [Activity]
   708 E C1442161:Deletion [Cell or Molecular Dysfunction]
   708 E C1511760:Deletion [Genetic Function]
Processing 00000000.tx.181: Very little is known about the relationship between the basis of these diverse genetic entities besides the 2distinct critical regions of loss identified at 5q31.22,23 A rare case of RAEB may show noncontiguous deletions of both 5q31 loci,24 whereas other cases of RA have also been reported with del(5)(q11q13).25 The evidence provided here identifies a distinct refractory subset in which the D5S2634-D5S2029/D5S806 interval is consistently lost and the TP53 gene is mutated. 

Phrase: "Very little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the relationship"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205309:Known [Qualitative Concept]
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "between the basis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1527178:Basis [Functional Concept]
  1000   C1874451:Basis [Pharmacologic Substance]

Phrase: "of these diverse genetic entities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1551338:Entity [Entity]

Phrase: "besides the 2distinct critical regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]

Phrase: "of loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517945:Loss [Quantitative Concept]

Phrase: "identified at 5q31.22,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C0796362:5q31 [Cell Component]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "A rare case of RAEB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "may"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "noncontiguous deletions of both 5q31 loci,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1880274:Deletions [Activity]
   719 E C1442161:Deletion [Cell or Molecular Dysfunction]
   719 E C1511760:Deletion [Genetic Function]

Phrase: "24"

Phrase: "whereas"

Phrase: "other cases of RA"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "reported with del(5"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0008628:del [Cell or Molecular Dysfunction]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: ")"

Phrase: "(q11q13"

Phrase: ").25"

Phrase: "The evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "here"

Phrase: "identifies"

Phrase: "a distinct refractory subset in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1515021:Subset [Classification]

Phrase: "the D5S2634-D5S2029/D5S806 interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]

Phrase: "is"

Phrase: "consistently"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "and"

Phrase: "the TP53 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:TP53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "mutated."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.182: Nature of TP53 mutations All the mutations we identified were in the DNA binding domain of TP53. 

Phrase: "Nature of TP53 mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349590:Nature [Idea or Concept]
   770   C1262865:Nature [Functional Concept]

Phrase: "All the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "were in the DNA binding domain of TP53."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C1511662:DNA Binding Domain [Amino Acid Sequence]
   770   C1148673:DNA Binding [Genetic Function]
   744   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1880389:Domain [Functional Concept]
   744   C1883221:Domain [Conceptual Entity]
   744   C3541951:Domain [Intellectual Product]
Processing 00000000.tx.183: Of the 5TP53 mutations that we identified, 2were not typical. 

Phrase: "Of the 5TP53 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "2were"

Phrase: "not typical."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538928:Typical [Qualitative Concept]
Processing 00000000.tx.184: Codon 220is a common site for mutation, but is usually a change from Tyr to Cys. 

Phrase: "Codon 220is"

Phrase: "a common site for mutation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]

Phrase: "but"

Phrase: "is"

Phrase: "usually"

Phrase: "a change from Tyr"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "to Cys."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.185: Codon 294is rarely mutated.26 Only 3of the 5mutations that we identified were transition mutations indicating that the common C to T transition mutation seen in solid tumors may not be the only mechanism of mutation in leukemia. 

Phrase: "Codon 294is rarely"

Phrase: "mutated.26 Only 3of"

Phrase: "the 5mutations"

Phrase: "that"

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "were"

Phrase: "transition mutations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709093:Transition Mutations [Cell or Molecular Dysfunction]
   983 E C0599156:Transition Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "indicating"

Phrase: "that"

Phrase: "the common C to T transition mutation"

Phrase: "seen in solid tumors"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0280100:solid tumors [Neoplastic Process]
   770   C0027651:Tumors [Neoplastic Process]
   770   C0205208:Solid [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   770   C0302909:Solid [Substance]
   770   C1378566:Solid [Biomedical or Dental Material]
   737 E C0042789:see [Organism Function]
   737 E C1578706:Tumor [Intellectual Product]
   737 E C1947903:See [Activity]
   737 E C3273930:Tumor [Finding]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "the only mechanism of mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "in leukemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:Leukaemia [Neoplastic Process]
Processing 00000000.tx.186: A larger survey of TP53 mutations in secondary AML and MDS will be useful in understanding the mechanism as the mutational spectra in MDS and AML may be different from other cancers.27 Loss of 5q13.3 locus precedes mutations in the TP53 gene Patient 1allows us to conclude that deletions of 5q and 17p loci precede the TP53 inactivation although clonal expansion of cells harboring der(5;17) is clearly evident, as shown in Table 2. 

Phrase: "A larger survey of TP53 mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0038951:Survey [Intellectual Product]

Phrase: "in secondary AML"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0280449:secondary acute myelogenous leukemia [Neoplastic Process]
   923   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   902   C0856053:secondary leukemia [Neoplastic Process]
   875   C0085669:Acute leukaemia [Neoplastic Process]
   875   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C0023470:Myelogenous Leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0205178:acute [Temporal Concept]
   812   C0439677:Myelogenous [Qualitative Concept]

Phrase: "and"

Phrase: "MDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "will"

Phrase: "be"

Phrase: "useful in understanding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0042153:use [Functional Concept]
   718   C0457083:Use [Functional Concept]
   718   C1947944:Use [Intellectual Product]

Phrase: "the mechanism as the mutational spectra"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "in MDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "and"

Phrase: "AML"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "different from other cancers.27 Loss of 5q13.3 locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "precedes"

Phrase: "mutations in the TP53 gene Patient 1allows"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that deletions of 5q"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   802   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "and"

Phrase: "17p loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "precede"

Phrase: "the TP53 inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "although"

Phrase: "clonal expansion of cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1516670:Clonal Expansion [Pathologic Function]
   802   C0007595:cell expansion [Cell Function]
   783   C0009013:Clone Cells [Cell]
   770   C1522642:Clonal [Tissue]
   770   C1704387:Clonal [Qualitative Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511780:der [Cell or Molecular Dysfunction]

Phrase: ";17"

Phrase: ")"

Phrase: "is"

Phrase: "clearly evident,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "as"

Phrase: "shown in Table 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.187: She was asymptomatic during the evolution of the der(5;17) clone suggesting that the unbalanced translocation conferred a proliferative advantage and did not affect the differentiation potential. 

Phrase: "She"

Phrase: "was"

Phrase: "asymptomatic during the evolution of the der(5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0231221:Asymptomatic [Finding]

Phrase: ";17"

Phrase: ")"

Phrase: "clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the unbalanced translocation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519758:Unbalanced Translocation [Cell or Molecular Dysfunction]
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "conferred"

Phrase: "a proliferative advantage"

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the differentiation potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.188: Deletion of chromosome 5q is also seen as an acquired anomaly in familial AML and MDS without genetic linkage to chromosome 5q.28 Taken together, the early events leading to the initiation of a dysplastic clone may be independent of loss of chromosome 5q; 

Phrase: "Deletion of chromosome 5q"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   909   C0008628:Deletion of chromosome NOS [Cell or Molecular Dysfunction]
           Chromosome Deletion
   819   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   770   C1442161:Deletion [Cell or Molecular Dysfunction]
   770   C1511760:Deletion [Genetic Function]
   770   C1880274:Deletion [Activity]

Phrase: "is"

Phrase: "also"

Phrase: "seen as an acquired anomaly"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0221430:Acquired anomaly [Acquired Abnormality]
   760   C0205397:Seen [Qualitative Concept]
   760   C0439661:Acquired [Temporal Concept]
   760   C1704258:Anomaly [Finding]
   760   C3245488:acquired [Intellectual Product]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "in familial AML"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   875   C0085669:Acute leukaemia [Neoplastic Process]
   875   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   861   C0023470:Myelogenous Leukemia [Neoplastic Process]
   812   C0023418:Leukaemia [Neoplastic Process]
   812   C0205178:acute [Temporal Concept]
   812   C0439677:Myelogenous [Qualitative Concept]

Phrase: "and"

Phrase: "MDS without genetic linkage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026985:Myelodysplasia [Congenital Abnormality]
   770   C0026986:Myelodysplasia [Neoplastic Process]
   770   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "to chromosome 5q.28"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0796347:chromosome 5q [Nucleotide Sequence]
           5q
   827   C0008633:Chromosome [Cell Component]
   827   C1521461:5q- [Cell or Molecular Dysfunction]

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "the early events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441471:Events [Event]
   861   C3541888:Events [Classification]

Phrase: "leading to the initiation of a dysplastic clone"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   744   C0009013:Clone [Cell]
   744   C0332152:Leading [Temporal Concept]
   744   C0334044:Dysplastic [Pathologic Function]
   744   C0589507:Initiation [Mental Process]
   744   C1158830:Initiation [Genetic Function]
   744   C1522538:Leading [Functional Concept]
   744   C1522642:Clone [Tissue]
   744   C1704686:Initiation [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be independent of loss of chromosome 5q"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   831   C1521461:Loss of Chromosome 5q [Cell or Molecular Dysfunction]
           5q-
   778   C0332291:Independent of [Functional Concept]
   778   C0796347:chromosome 5q [Nucleotide Sequence]
           5q
   774   C0598174:chromosome loss [Genetic Function]
   748   C0008633:Chromosome [Cell Component]
   748   C0085862:Independent [Idea or Concept]
   748   C1299583:Independent [Finding]
   748   C1517945:Loss [Quantitative Concept]
   748   C2987476:Be [Conceptual Entity]
   738 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.189: whereas, deletions in 5q may allow an expansion of the clone that can then be transformed by mutations on TP53 or other genetic alterations. 

Phrase: "whereas"

Phrase: ","

Phrase: "deletions in 5q"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   841   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   790   C1880274:Deletions [Activity]
   756 E C1442161:Deletion [Cell or Molecular Dysfunction]
   756 E C1511760:Deletion [Genetic Function]

Phrase: "may"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "an expansion of the clone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1516670:Clonal Expansion [Pathologic Function]

Phrase: "that"

Phrase: "can"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "transformed by mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026882:Mutations [Genetic Function]
   790   C1510411:Transformed [Pathologic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on TP53"

Phrase: "or"

Phrase: "other genetic alterations."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0026882:Genetic Alteration [Genetic Function]
   983   C1704257:Genetic Alteration [Finding]
   983   C1705285:Genetic Alteration [Cell or Molecular Dysfunction]
   827   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.190: Figure 6 illustrates a proposed order and functional consequences of the somatic mutations during the progression of MDS and AML. 

Phrase: "Figure 6"

Phrase: "illustrates"

Phrase: "a proposed order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "and"

Phrase: "functional consequences of the somatic mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C0686907:Consequence of [Functional Concept]
           consequences

Phrase: "during the progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "of MDS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "and"

Phrase: "AML."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]
Processing 00000000.tx.191: As TP53 mutations are infrequent in refractory MDS and AML, there are likely to be other genetic alterations that would also facilitate transformation in cells with deletions of chromosome 5.To support this model, additional patients with chromosome 5and 17abnormalities will be studied in the future. 

Phrase: "As TP53 mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "infrequent in refractory MDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521114:Infrequent [Temporal Concept]

Phrase: "and"

Phrase: "AML,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: "there"

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "other genetic alterations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0026882:Genetic Alteration [Genetic Function]
   983   C1704257:Genetic Alteration [Finding]
   983   C1705285:Genetic Alteration [Cell or Molecular Dysfunction]
   827   C1515926:Alteration [Idea or Concept]

Phrase: "that"

Phrase: "would"

Phrase: "also"

Phrase: "facilitate"

Phrase: "transformation in cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C0040682:cell transformation [Cell Function]
           Transformation
   841   C1510411:Cell Transformation [Pathologic Function]
           Transformation
   790   C1705163:Transformation [Research Activity]

Phrase: "with deletions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880274:Deletions [Activity]
   966 E C1442161:Deletion [Cell or Molecular Dysfunction]
   966 E C1511760:Deletion [Genetic Function]

Phrase: "of chromosome 5.To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0008668:Chromosome 5 [Cell Component]
   827   C0008633:Chromosome [Cell Component]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "additional patients with chromosome 5and 17abnormalities"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030705:Patients [Patient or Disabled Group]

Phrase: "will"

Phrase: "be"

Phrase: "studied in the future."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016884:Future [Temporal Concept]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]
Processing 00000000.tx.192: Furthermore, the placement of TP53 mutation late in the sequence of events is reminiscent of the colon cancer model of transformation.29 View larger version (10K): [in this window] [in a new window]  Fig 6. 

Phrase: "Furthermore,"

Phrase: "the placement of TP53 mutation late"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441587:Placement [Health Care Activity]
   753   C1524072:Placement [Qualitative Concept]

Phrase: "in the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "of events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "is"

Phrase: "reminiscent of the colon cancer model of transformation.29 View larger version"

Phrase: "(10K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig 6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]
Processing 00000000.tx.193: Sequence of genetic alterations in patient 1. 

Phrase: "Sequence of genetic alterations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   802   C0596611:Sequence Alteration [Genetic Function]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "in patient 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.194: A normal myeloid stem cell that acquires loss of 5q13 and 17p loci confers a prolifertaive advantage. 

Phrase: "A normal myeloid stem cell"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0596993:Myeloid stem cell [Cell]
           Myeloid cell
   902   C0007634:Normal cell [Cell]
           Cell
   902   C1268443:Normal cell [Cell]
   875   C0887899:Myeloid Cell [Cell]
   861   C0038250:Stem cell [Cell]
   812   C0242767:Stem [Plant]
   812   C1186763:Stem [Body Part, Organ, or Organ Component]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "acquires"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1706701:Acquire [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "loss of 5q13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "17p loci"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708726:Locus [Gene or Genome]

Phrase: "confers"

Phrase: "a prolifertaive advantage."
Processing 00000000.tx.195: The clone accumulates additional chromosomal alterations after inactivation of the TP53 gene. 

Phrase: "The clone"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]
   928 E C1704387:Clonal [Qualitative Concept]
   900 E C0796368:clonality [Diagnostic Procedure]

Phrase: "accumulates"

Phrase: "additional chromosomal alterations after inactivation of the TP53 gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0008625:Chromosomal Alterations [Cell or Molecular Dysfunction]
   745   C0596611:Gene Alteration [Genetic Function]
   708   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.196: The resulting acute leukemic clone with the numerous cytogenetic alterations is highly refractory to therapy.  

Phrase: "The resulting acute leukemic clone with the numerous cytogenetic alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0009013:Clone [Cell]
   739   C1522642:Clone [Tissue]

Phrase: "is"

Phrase: "highly refractory to therapy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205269:Refractory [Functional Concept]
Processing 00000000.tx.197: Acknowledgments Our special thanks are due to Dr Elihu Estey for helpful discussions on patient 1.We thank Drs Miloslav Beran, David Claxton, Steven Kornblau, and Susan Roberts for patient material and Dr Hong Liang for helpful discussions. 

Phrase: "Acknowledgments"

Phrase: "Our special"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205555:Special [Qualitative Concept]

Phrase: "thanks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "are due to Dr Elihu Estey"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0031831:DR [Professional or Occupational Group]
   753   C1551058:Are [Quantitative Concept]
   753   C1707664:DR [Biomedical or Dental Material]
   753   C2348314:Dr. [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]
   753   C3540849:DR [Idea or Concept]

Phrase: "for helpful discussions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]

Phrase: "on patient 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs Miloslav Beran,"

Phrase: "David Claxton,"

Phrase: "Steven Kornblau,"

Phrase: "and"

Phrase: "Susan Roberts for patient material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0331964:Roberts [Health Care Related Organization]

Phrase: "and"

Phrase: "Dr Hong Liang for helpful discussions."
Processing 00000000.tx.198: We also thank Rui Yu Wang, Xiuying Lina Wu, and Lisa Chu for assistance with FISH analysis and Rashmi Pershad for the automated DNA sequence analysis. 

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Rui Yu Wang,"

Phrase: "Xiuying Lina Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Lisa Chu for assistance"

Phrase: "with FISH analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
   771   C0162789:Fluorescent in Situ Hybridization [Molecular Biology Research Technique]
   717   C0162788:In Situ Hybridization [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "Rashmi Pershad for the automated DNA sequence analysis."
Processing 00000000.tx.199: The enthusiastic assistance of Gisela Sanchez William and Ellen Jackson with the patient database is gratefully acknowledged. 

Phrase: "The enthusiastic assistance of Gisela Sanchez William"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0018896:Assistance [Social Behavior]

Phrase: "and"

Phrase: "Ellen Jackson with the patient database"

Phrase: "is"

Phrase: "gratefully"

Phrase: "acknowledged."
Processing 00000000.tx.200: We thank Dr Walter Hittelman for critical reading of the manuscript.  

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Walter Hittelman for critical reading of the manuscript."
Processing 00000000.tx.201: Footnotes Submitted July 12,1999; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted July 12,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "1999"

Phrase: ";"
Processing 00000000.tx.202: accepted November 30,1999. 

Phrase: "accepted November 30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1999."
Processing 00000000.tx.203: Supported by grants from Ladies Leukemia League, Metairie, LA, CA66982 and CA55164 from the National Institutes of Health. 

Phrase: "Supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from Ladies Leukemia League,"

Phrase: "Metairie,"

Phrase: "LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023031:La [Element, Ion, or Isotope]

Phrase: "CA66982"

Phrase: "and"

Phrase: "CA55164 from the National Institutes of Health."
Processing 00000000.tx.204: Reprints: Lalitha Nagarajan, Department of Molecular Genetics, Box 45,M.D.

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Lalitha Nagarajan,"

Phrase: "Department of Molecular Genetics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0587466:Genetics department [Health Care Related Organization]
   770   C1704729:Department [Organization]

Phrase: "Box 45,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.205: Anderson Cancer Center, 1515Holcombe Blvd, Houston, TX 77030; 

Phrase: "Anderson Cancer Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1513817:Cancer Center [Health Care Related Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "1515Holcombe Blvd,"

Phrase: "Houston,"

Phrase: "TX 77030"

Phrase: ";"
Processing 00000000.tx.206: e-mail: lalitha{at}odin.mdacc.tmc.edu . The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "lalitha{at}odin.mdacc.tmc.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.207: Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18U.S.C. section 1734.  

Phrase: "Therefore,"

Phrase: "and"

Phrase: "solely to"

Phrase: "indicate"

Phrase: "this fact,"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C. section 1734."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205155:Section [Spatial Concept]
   804   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   804   C1522472:Section [Substance]
   804   C1552923:Section [Quantitative Concept]
   804   C1705191:Section [Physical Object]
Processing 00000000.tx.208: References Top Abstract Introduction Materials and methods Results Discussion References 1. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.209: Fairman J, Wang RY, Liang H, et al. 

Phrase: "Fairman J,"

Phrase: "Wang RY,"

Phrase: "Liang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.210: Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. 

Phrase: "Translocations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040715:Translocations [Cell or Molecular Dysfunction]
   966 E C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "deletions of 5q13.1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1880274:Deletions [Activity]
   737 E C1442161:Deletion [Cell or Molecular Dysfunction]
   737 E C1511760:Deletion [Genetic Function]

Phrase: "in myelodysplasia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026985:Myelodysplasia [Congenital Abnormality]
  1000   C0026986:Myelodysplasia [Neoplastic Process]
  1000   C0033027:myelodysplasia [Neoplastic Process]

Phrase: "and"

Phrase: "acute myelogenous leukemia"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]

Phrase: ":"

Phrase: "evidence for a novel critical locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.211: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.212: 1996;88:2259[Abstract/Free FullText]. 

Phrase: "1996"

Phrase: ";88"

Phrase: ":"

Phrase: "2259"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.213: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.214: Estey EH, Keating MJ, Dixon DO, Trujillo JM, McCredie KB, Freireich EJ. 

Phrase: "Estey EH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1520135:EH [Geographic Area]

Phrase: "Keating MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Dixon"

Phrase: "DO"

Phrase: ","

Phrase: "Trujillo JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "McCredie KB,"

Phrase: "Freireich EJ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1718783:Ej [Immunologic Factor]
Processing 00000000.tx.215: Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. 

Phrase: "Karyotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022526:Karyotype [Laboratory Procedure]
  1000   C0178725:Karyotype [Laboratory or Test Result]
  1000   C1261273:Karyotype [Organism Attribute]

Phrase: "is"

Phrase: "prognostically more important than the FAB system's distinction"

Phrase: "between myelodysplastic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0026986:Myelodysplastic syndrome [Neoplastic Process]
  1000   C0033027:myelodysplastic syndrome [Neoplastic Process]
  1000   C3463824:MYELODYSPLASTIC SYNDROME [Neoplastic Process]
  1000   C3538995:Myelodysplastic Syndrome [Intellectual Product]
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "and"

Phrase: "acute myelogenous leukemia."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]
Processing 00000000.tx.216: Hematol Pathol. 

Phrase: "Hematol Pathol."
Processing 00000000.tx.217: 1987;1:203[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1987"

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "203"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.218: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.219: Keating MJ, Cork A, Broach Y, et al. 

Phrase: "Keating MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Cork A,"

Phrase: "Broach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0179429:BROACH [Medical Device]

Phrase: "Y,"

Phrase: "et al."
Processing 00000000.tx.220: Towards a clinically relevant cytogenetic classification of acute myelogenous leukemia. 

Phrase: "Towards a clinically relevant cytogenetic classification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0008902:Classification [Classification]
   812   C0008903:classification [Functional Concept]
   812   C0678229:classification [Occupational Activity]

Phrase: "of acute myelogenous leukemia."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0023467:Acute myelogenous leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Myelogenous Leukemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]
   827   C0439677:Myelogenous [Qualitative Concept]
Processing 00000000.tx.221: Leukemia Res. 

Phrase: "Leukemia Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.222: 1987;11:119[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1987"

Phrase: ";11"

Phrase: ":"

Phrase: "119"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.223: 4. 

Phrase: "4."
Processing 00000000.tx.224: Jonveaux P, Fenaux P, Quiquandon I, et al. 

Phrase: "Jonveaux P,"

Phrase: "Fenaux P,"

Phrase: "Quiquandon I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "et al."
Processing 00000000.tx.225: Mutations in the p53 gene in myelodysplastic syndromes. 

Phrase: "Mutations in the p53 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in myelodysplastic syndromes."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026986:Myelodysplastic Syndromes [Neoplastic Process]
   966 E C0033027:myelodysplastic syndrome [Neoplastic Process]
   966 E C3463824:MYELODYSPLASTIC SYNDROME [Neoplastic Process]
   966 E C3538995:Myelodysplastic Syndrome [Intellectual Product]
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]
Processing 00000000.tx.226: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.227: 1991;6:2243[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1991"

Phrase: ";6"

Phrase: ":"

Phrase: "2243"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.228: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.229: Wieland I, Bohm M, Arden KC, et al. 

Phrase: "Wieland I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bohm M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Arden KC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022575:kc [Disease or Syndrome]
   861   C1705783:KC [Gene or Genome]

Phrase: "et al."
Processing 00000000.tx.230: Allelic deletion mapping on chromosome 5in human carcinomas. 

Phrase: "Allelic deletion mapping on chromosome 5in human carcinomas."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0008630:Chromosome Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   744   C1283195:Mapping [Activity]
Processing 00000000.tx.231: Oncogene. 

Phrase: "Oncogene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029016:Oncogene [Gene or Genome]
Processing 00000000.tx.232: 1996;12:97[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1996"

Phrase: ";12"

Phrase: ":"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.233: 6. 

Phrase: "6."
Processing 00000000.tx.234: Cunningham JM, Shan A, Wick MJ, et al. 

Phrase: "Cunningham JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Shan A,"

Phrase: "Wick MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "et al."
Processing 00000000.tx.235: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. 

Phrase: "Allelic imbalance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0887935:Allelic Imbalance [Cell or Molecular Dysfunction]
   861   C1397014:Imbalance [Sign or Symptom]

Phrase: "and"

Phrase: "microsatellite instability in prostatic adenocarcinoma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0796369:microsatellite instability [Diagnostic Procedure]
   806   C0920269:Microsatellite Instability [Pathologic Function]
   760   C1444783:Instability [Finding]
   760   C1519302:Microsatellite [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.236: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.237: 1996;56:4475[Abstract]. 

Phrase: "1996"

Phrase: ";56"

Phrase: ":"

Phrase: "4475"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.238: 7. 

Phrase: "7."
Processing 00000000.tx.239: Tavassoli M, Steingrimsdottir H, Pierce E, et al. 

Phrase: "Tavassoli M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Steingrimsdottir H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Pierce E,"

Phrase: "et al."
Processing 00000000.tx.240: Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. 

Phrase: "Loss of heterozygosity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524869:Loss of Heterozygosity [Genetic Function]
           Heterozygosity Loss
   790   C1517945:Loss [Quantitative Concept]

Phrase: "on chromosome 5q"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0796347:chromosome 5q [Nucleotide Sequence]
           5q
   861   C1521461:5q- [Cell or Molecular Dysfunction]

Phrase: "in ovarian cancer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0029925:ovarian cancer [Neoplastic Process]
  1000   C1140680:Ovarian Cancer [Neoplastic Process]
   861   C0006826:Cancer [Neoplastic Process]
   861   C0205065:Ovarian [Body Part, Organ, or Organ Component]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "is"

Phrase: "frequently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Frequently [Temporal Concept]

Phrase: "accompanied by TP53 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "identifies"

Phrase: "a tumour suppressor gene locus at 5q13.1-21."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1708726:Gene Locus [Gene or Genome]
           Locus
Processing 00000000.tx.241: Br J Cancer. 

Phrase: "Br J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.242: 1996;74:115[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1996"

Phrase: ";74"

Phrase: ":"

Phrase: "115"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.243: 8. 

Phrase: "8."
Processing 00000000.tx.244: Tamura G, Ogasawara S, Nishizuka S, et al. 

Phrase: "Tamura G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Ogasawara S,"

Phrase: "Nishizuka S,"

Phrase: "et al."
Processing 00000000.tx.245: Two distinct regions of deletion on the long arm of chromosome 5in differentiated adenocarcinomas of the stomach. 

Phrase: "Two distinct regions of deletion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0017446:Region [Geographic Area]
   726   C0205147:Region [Spatial Concept]

Phrase: "on the long arm"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0575519:Long arm [Finding]
   861   C0446516:Arm [Body Location or Region]
   861   C1269078:Arm [Body Part, Organ, or Organ Component]
   861   C1269612:Arm [Body Location or Region]
   805 E C0445456:Brachial [Spatial Concept]
   777 E C0206655:ARMS [Neoplastic Process]
   777 E C2681631:ARMS [Gene or Genome]

Phrase: "of chromosome 5in differentiated adenocarcinomas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001418:Adenocarcinomas [Neoplastic Process]

Phrase: "of the stomach."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0038351:Stomach [Body Part, Organ, or Organ Component]
  1000   C1278920:Stomach [Body Part, Organ, or Organ Component]
  1000   C1517454:STOMACH [Tissue]
   944 E C1704242:Gastric [Qualitative Concept]
Processing 00000000.tx.246: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.247: 1996;56:612[Abstract]. 

Phrase: "1996"

Phrase: ";56"

Phrase: ":"

Phrase: "612"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.248: 9. 

Phrase: "9."
Processing 00000000.tx.249: Achille A, Baron A, Zamboni G, Di Pace C, Orlandini S, Scarpa A. 

Phrase: "Achille"

Phrase: "A,"

Phrase: "Baron A,"

Phrase: "Zamboni G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Di Pace C,"

Phrase: "Orlandini S,"

Phrase: "Scarpa A."
Processing 00000000.tx.250: Chromosome 5allelic losses are early events in tumours of the papilla of Vater and occur at sites similar to those of gastric cancer. 

Phrase: "Chromosome 5allelic losses"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C0598174:chromosome loss [Genetic Function]
   861 E C1516519:Chromosomal Loss [Cell or Molecular Dysfunction]
   793   C1517945:Loss [Quantitative Concept]

Phrase: "are"

Phrase: "early events in tumours of the papilla of Vater"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0441471:Events [Event]
   742   C3541888:Events [Classification]

Phrase: "and"

Phrase: "occur at sites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205145:Sites [Spatial Concept]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   756 E C1515974:Site [Body Location or Region]
   756 E C2825164:Site [Spatial Concept]

Phrase: "similar to those of gastric cancer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.251: Br J Cancer. 

Phrase: "Br J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.252: 1998;78:1653[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";78"

Phrase: ":"

Phrase: "1653"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.253: 10. 

Phrase: "10."
Processing 00000000.tx.254: Atkin NB, Fox MF. 

Phrase: "Atkin NB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0919442:NB [Gene or Genome]
   861   C1705347:NB [Gene or Genome]

Phrase: "Fox MF."
Processing 00000000.tx.255: 5q deletion. 

Phrase: "5q deletion."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]
Processing 00000000.tx.256: The sole chromosome change in a carcinoma of the bladder. 

Phrase: "The sole chromosome change in a carcinoma of the bladder."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0025320:The change [Physiologic Function]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.257: Cancer Genet Cytogenet. 

Phrase: "Cancer Genet Cytogenet."
Processing 00000000.tx.258: 1990;46:129[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1990"

Phrase: ";46"

Phrase: ":"

Phrase: "129"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.259: 11. 

Phrase: "11."
Processing 00000000.tx.260: Lai JL, Preudhomme C, Zandecki M, et al. 

Phrase: "Lai JL,"

Phrase: "Preudhomme C,"

Phrase: "Zandecki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.261: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. 

Phrase: "Myelodysplastic syndromes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026986:Myelodysplastic Syndromes [Neoplastic Process]
   966 E C0033027:myelodysplastic syndrome [Neoplastic Process]
   966 E C3463824:MYELODYSPLASTIC SYNDROME [Neoplastic Process]
   966 E C3538995:Myelodysplastic Syndrome [Intellectual Product]
   861   C0039082:Syndromes [Disease or Syndrome]
   861   C1558916:SYNDROMES [Finding]

Phrase: "and"

Phrase: "acute myeloid leukemia with 17p deletion."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0023467:Acute myeloid leukaemia [Neoplastic Process]
   833   C2984331:Acute myeloid leukemia [Functional Concept]
   833   C3541370:Acute Myeloid Leukemia [Intellectual Product]
   790   C0023470:Myeloid Leukemia [Neoplastic Process]
   783   C0085669:Acute leukaemia [Neoplastic Process]
   783   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   753   C0023418:Leukaemia [Neoplastic Process]
   753   C0205178:acute [Temporal Concept]
   753   C0439677:Myeloid [Qualitative Concept]
Processing 00000000.tx.262: An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations. 

Phrase: "An entity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551338:Entity [Entity]

Phrase: "characterized by specific dysgranulopoiesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]
   770   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "a high incidence of P53 mutations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0021149:Incidence [Quantitative Concept]
   753   C0220856:incidence [Functional Concept]
Processing 00000000.tx.263: Leukemia. 

Phrase: "Leukemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:Leukaemia [Neoplastic Process]
Processing 00000000.tx.264: 1995;9:370[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1995"

Phrase: ";9"

Phrase: ":"

Phrase: "370"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.265: 12. 

Phrase: "12."
Processing 00000000.tx.266: Soenen V, Preudhomme C, Roumier C, Daudignon A, Lai JL, Fenaux P. 

Phrase: "Soenen V,"

Phrase: "Preudhomme C,"

Phrase: "Roumier C,"

Phrase: "Daudignon A,"

Phrase: "Lai JL,"

Phrase: "Fenaux P."
Processing 00000000.tx.267: 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. 

Phrase: "17p Deletion in acute myeloid leukemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1442161:Deletion [Cell or Molecular Dysfunction]
   753   C1511760:Deletion [Genetic Function]
   753   C1880274:Deletion [Activity]

Phrase: "and"

Phrase: "myelodysplastic syndrome."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0026986:Myelodysplastic syndrome [Neoplastic Process]
  1000   C0033027:myelodysplastic syndrome [Neoplastic Process]
  1000   C3463824:MYELODYSPLASTIC SYNDROME [Neoplastic Process]
  1000   C3538995:Myelodysplastic Syndrome [Intellectual Product]
   861   C0039082:Syndrome [Disease or Syndrome]
Processing 00000000.tx.268: Analysis of breakpoints and deleted segments by fluorescence in situ. 

Phrase: "Analysis of breakpoints"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "deleted segments by fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0441635:Segment [Spatial Concept]

Phrase: "in situ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444498:In situ [Spatial Concept]
Processing 00000000.tx.269: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.270: 1998;91:1008[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";91"

Phrase: ":"

Phrase: "1008"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.271: 13. 

Phrase: "13."
Processing 00000000.tx.272: Wang P, Spielberger RT, Thangavelu M, et al. 

Phrase: "Wang P,"

Phrase: "Spielberger RT,"

Phrase: "Thangavelu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "et al."
Processing 00000000.tx.273: dic(5;17): a recurring abnormality in malignant myeloid disordersassociated with mutations of TP53. 

Phrase: "dic(5"

Phrase: ";17"

Phrase: ")"

Phrase: ":"

Phrase: "a recurring abnormality in malignant myeloid disordersassociated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704258:Abnormality [Finding]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of TP53."
Processing 00000000.tx.274: Genes Chromosomes Cancer. 

Phrase: "Genes Chromosomes Cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0919437:genes cancer [Gene or Genome]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.275: 1997;20:282[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1997"

Phrase: ";20"

Phrase: ":"

Phrase: "282"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.276: 14. 

Phrase: "14."
Processing 00000000.tx.277: Fairman J, Claxton D, Williman CL, Deisseroth AB, Nagarajan L. 

Phrase: "Fairman J,"

Phrase: "Claxton D,"

Phrase: "Williman CL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "Deisseroth AB,"

Phrase: "Nagarajan L."
Processing 00000000.tx.278: Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm. 

Phrase: "Development of a sensitive PCR to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0243107:development [Physiologic Function]
   744   C0678723:Development [Organism Function]
   744   C1527148:Development [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "allele loss in a model hematopoietic neoplasm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1517945:Loss [Quantitative Concept]
   737   C0524869:Allelic Loss [Genetic Function]
Processing 00000000.tx.279: PCR Methods Appl. 

Phrase: "PCR Methods Appl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1858559:APPL [Gene or Genome]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.280: 1994;4:6[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1994"

Phrase: ";4"

Phrase: ":"

Phrase: "6"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.281: 15. 

Phrase: "15."
Processing 00000000.tx.282: Silverman GA. 

Phrase: "Silverman GA."
Processing 00000000.tx.283: Isolating vector-insert junctions from yeast artificial chromosomes. 

Phrase: "Isolating vector-insert junctions from yeast artificial chromosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0205144:Junction [Spatial Concept]
   711   C1706311:Junction [Medical Device]
Processing 00000000.tx.284: PCR Methods Appl. 

Phrase: "PCR Methods Appl."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1858559:APPL [Gene or Genome]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.285: 1993;3:141[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "141"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.286: 16. 

Phrase: "16."
Processing 00000000.tx.287: Kozbor D, Tripputi P, Roder JC, Croce CM. 

Phrase: "Kozbor D,"

Phrase: "Tripputi P,"

Phrase: "Roder JC,"

Phrase: "Croce CM."
Processing 00000000.tx.288: A human hybrid myeloma for production of human monoclonal antibodies. 

Phrase: "A human hybrid myeloma for production of human monoclonal antibodies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0026764:Myeloma [Neoplastic Process]
   739   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.289: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.290: 1984;133:3001[Abstract/Free FullText]. 

Phrase: "1984"

Phrase: ";133"

Phrase: ":"

Phrase: "3001"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.291: 17. 

Phrase: "17."
Processing 00000000.tx.292: Liu P, Siciliano J, Seong D, et al. 

Phrase: "Liu P,"

Phrase: "Siciliano J,"

Phrase: "Seong D,"

Phrase: "et al."
Processing 00000000.tx.293: Dual Alu polymerase chain reaction primers and conditions for isolation of human chromosome painting probes from hybrid cells. 

Phrase: "Dual Alu polymerase chain reaction primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "conditions for isolation of human chromosome painting probes"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   770   C0008643:Human Chromosome [Cell Component]
   770   C0600509:Chromosome Painting [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0008633:Chromosome [Cell Component]
   744   C0012634:condition [Disease or Syndrome]
   744   C0030208:painting [Intellectual Product,Manufactured Object]
   744   C0086418:Human [Human]
   744   C0182400:Probes [Medical Device]
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]
   744   C0348080:Condition [Qualitative Concept]
   744   C1705253:Condition [Conceptual Entity]
   731   C0008599:Chromosomal Probes [Indicator, Reagent, or Diagnostic Aid,Nucleic Acid, Nucleoside, or Nucleotide]
   711 E C0030206:Paint [Manufactured Object]
   711 E C1704681:Probe [Gene or Genome]
   711 E C2347609:Probe [Chemical Viewed Functionally]
   711 E C3536729:Probe [Manufactured Object]

Phrase: "from hybrid cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0020200:Hybrid Cells [Cell]
   966 E C0007597:hybrid cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C0020205:Hybrid [Organism]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.294: Cancer Genet Cytogenet. 

Phrase: "Cancer Genet Cytogenet."
Processing 00000000.tx.295: 1993;65:93[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ":"

Phrase: "93"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.296: 18. 

Phrase: "18."
Processing 00000000.tx.297: Zhao L, van Oort J, Cork A, Liang JC. 

Phrase: "Zhao L,"

Phrase: "van Oort J,"

Phrase: "Cork A,"

Phrase: "Liang JC."
Processing 00000000.tx.298: Comparison between interphase and metaphase cytogenetics in detecting chromosome 7defects in hematological neoplasias. 

Phrase: "Comparison between interphase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "metaphase cytogenetics in detecting chromosome 7defects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010802:Cytogenetics [Biomedical Occupation or Discipline]

Phrase: "in hematological neoplasias."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027651:neoplasias [Neoplastic Process]
   777 E C1709160:Neoplastic [Qualitative Concept]
Processing 00000000.tx.299: Am J Hematol. 

Phrase: "Am"

Phrase: "J Hematol."
Processing 00000000.tx.300: 1993;43:205[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";43"

Phrase: ":"

Phrase: "205"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.301: 19. 

Phrase: "19."
Processing 00000000.tx.302: Le Beau MM, Albain KS, Larson RA, et al. 

Phrase: "Le Beau MM,"

Phrase: "Albain KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Larson RA,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0002893:Anemia, Refractory [Disease or Syndrome]
   901   C2981142:Refractory anaemia [Disease or Syndrome]
   827   C0002871:Anaemia [Disease or Syndrome]
   827   C0205269:Refractory [Functional Concept]
   827   C1000483:Anemia [Plant]
   755 E C0857322:anaemic [Finding]

Phrase: "et al."
Processing 00000000.tx.303: Clinical and cytogenetic correlations in 63patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 

Phrase: "Clinical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205210:Clinical [Qualitative Concept]

Phrase: "and"

Phrase: "cytogenetic correlations in 63patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707520:Correlation [Qualitative Concept]

Phrase: "with therapy-related myelodysplastic syndromes"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
   988   C1292780:Therapy-related myelodysplastic syndrome [Neoplastic Process]
   861   C0026986:Myelodysplastic Syndromes [Neoplastic Process]
   827 E C0033027:myelodysplastic syndrome [Neoplastic Process]
   827 E C3463824:MYELODYSPLASTIC SYNDROME [Neoplastic Process]
   827 E C3538995:Myelodysplastic Syndrome [Intellectual Product]
   812   C0039082:Syndromes [Disease or Syndrome]
   812   C0039798:therapy [Functional Concept]
   812   C0087111:Therapy [Therapeutic or Preventive Procedure]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C1363945:Therapy [Finding]
   812   C1558916:SYNDROMES [Finding]
   779 E C0163712:Relate [Organic Chemical]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: "and"

Phrase: "acute nonlymphocytic leukemia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0023467:Acute non-lymphocytic leukaemia [Neoplastic Process]
   913   C0085669:Acute leukaemia [Neoplastic Process]
   913   C0280141:Acute Leukemia Not Otherwise Specified [Neoplastic Process]
   901   C0023470:Non-lymphocytic leukaemia [Neoplastic Process]
   827   C0023418:Leukaemia [Neoplastic Process]
   827   C0205178:acute [Temporal Concept]

Phrase: ":"

Phrase: "further evidence for characteristic abnormalities of chromosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "no."
Processing 00000000.tx.304: 5and 7. 

Phrase: "5and 7."
Processing 00000000.tx.305: J Clin Oncol. 

Phrase: "J Clin Oncol."
Processing 00000000.tx.306: 1986;4:325[Abstract/Free FullText]. 

Phrase: "1986"

Phrase: ";4"

Phrase: ":"

Phrase: "325"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.307: 20. 

Phrase: "20."
Processing 00000000.tx.308: Brothman AR, Maxwell TM, Cui J, Deubler DA, Zhu XL. 

Phrase: "Brothman AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Maxwell TM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0145779:TM [Amino Acid, Peptide, or Protein,Receptor]
   861   C3540468:TM [Gene or Genome]

Phrase: "Cui J,"

Phrase: "Deubler DA,"

Phrase: "Zhu XL."
Processing 00000000.tx.309: Chromosomal clues to the development of prostate tumors. 

Phrase: "Chromosomal clues to the development of prostate tumors."
Processing 00000000.tx.310: Prostate. 

Phrase: "Prostate."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033572:Prostate [Body Part, Organ, or Organ Component]
  1000   C1278980:Prostate [Body Part, Organ, or Organ Component]
Processing 00000000.tx.311: 1999;38:303[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";38"

Phrase: ":"

Phrase: "303"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.312: 21. 

Phrase: "21."
Processing 00000000.tx.313: Birch JM, Hartley AL, Tricker KJ, et al. 

Phrase: "Birch JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Hartley AL,"

Phrase: "Tricker KJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439255:kJ [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.314: Prevalence and diversity of constitutional mutations in the p53 gene among 21Li-Fraumeni families. 

Phrase: "Prevalence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033105:Prevalence [Quantitative Concept]
  1000   C0220900:prevalence [Quantitative Concept]

Phrase: "and"

Phrase: "diversity of constitutional mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880371:Diversity [Qualitative Concept]

Phrase: "in the p53 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079419:p53 gene [Gene or Genome]
  1000   C1705526:p53 gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "among 21Li-Fraumeni families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.315: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.316: 1994;54:1298[Abstract]. 

Phrase: "1994"

Phrase: ";54"

Phrase: ":"

Phrase: "1298"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.317: 22. 

Phrase: "22."
Processing 00000000.tx.318: Jaju RJ, Boultwood J, Oliver FJ, et al. 

Phrase: "Jaju RJ,"

Phrase: "Boultwood J,"

Phrase: "Oliver FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.319: Molecular cytogenetic delineation of the critical deleted region in the 5q-syndrome. 

Phrase: "Molecular cytogenetic delineation of the critical deleted region"

Phrase: "in the 5q-syndrome."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0740302:5q-syndrome [Disease or Syndrome]
  1000   C1292779:5q- Syndrome [Neoplastic Process]
  1000   C1802398:5q syndrome [Disease or Syndrome]
   861   C0039082:Syndrome [Disease or Syndrome]
   861   C0796347:5q [Nucleotide Sequence]
   861   C1521461:5q- [Cell or Molecular Dysfunction]
Processing 00000000.tx.320: Genes Chromosomes Cancer. 

Phrase: "Genes Chromosomes Cancer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0919437:genes cancer [Gene or Genome]
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.321: 1998;22:251[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";22"

Phrase: ":"

Phrase: "251"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.322: 23. 

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.323: Zhao N, Stoffel A, Wang PW, et al. 

Phrase: "Zhao N,"

Phrase: "Stoffel A,"

Phrase: "Wang PW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242397:PW [Geographic Area]

Phrase: "et al."
Processing 00000000.tx.324: Molecular delineation of the smallest commonly deleted region of chromosome 5in malignant myeloid diseases to 1-1.5Mb and preparation of a PAC-based physical map. 

Phrase: "Molecular delineation of the smallest commonly deleted region of chromosome 5in malignant myeloid diseases"

Phrase: "to 1-1.5Mb"

Phrase: "and"

Phrase: "preparation of a PAC-based physical map."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0455052:Preparation [Health Care Activity]
   748   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.325: Proc Natl Acad Sci U S A. 

Phrase: "Proc Natl Acad Sci U S A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.326: 1997;94:6948[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";94"

Phrase: ":"

Phrase: "6948"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.327: 24. 

Phrase: "24."
Processing 00000000.tx.328: Nagarajan L, Zhao L, Lu X, et al. 

Phrase: "Nagarajan L,"

Phrase: "Zhao L,"

Phrase: "Lu X,"

Phrase: "et al."
Processing 00000000.tx.329: 5q- chromosome: evidence for complex interstitial breaks in a case of refractory anemia with excess blasts. 

Phrase: "5q- chromosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008633:Chromosome [Cell Component]

Phrase: ":"

Phrase: "evidence for complex interstitial breaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in a case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of refractory anemia"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0002893:Anemia, Refractory [Disease or Syndrome]
  1000   C2981142:Refractory anaemia [Disease or Syndrome]
   861   C0002871:Anaemia [Disease or Syndrome]
   861   C0205269:Refractory [Functional Concept]
   861   C1000483:Anemia [Plant]
   789 E C0857322:anaemic [Finding]

Phrase: "with excess blasts."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337026:blasts [Natural Phenomenon or Process]
   861   C0368761:Blasts [Cell]
   861   C0523113:Blasts [Laboratory Procedure]
Processing 00000000.tx.330: Cancer Genet Cytogenet. 

Phrase: "Cancer Genet Cytogenet."
Processing 00000000.tx.331: 1994;74:8[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1994"

Phrase: ";74"

Phrase: ":"

Phrase: "8"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.332: 25. 

Phrase: "25."
Processing 00000000.tx.333: Kroef MJPL, Fibbe WE, Mout R, et al. 

Phrase: "Kroef MJPL,"

Phrase: "Fibbe"

Phrase: "WE,"

Phrase: "Mout R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "et al."
Processing 00000000.tx.334: Myeloid but not lymphoid cells carry the 5q deletion: polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. 

Phrase: "Myeloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439677:Myeloid [Qualitative Concept]

Phrase: "but"

Phrase: "not lymphoid cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086574:Lymphoid Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C1518071:Lymphoid [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "carry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:carry [Finding]

Phrase: "the 5q deletion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1521461:5q Deletion [Cell or Molecular Dysfunction]
   861   C1442161:Deletion [Cell or Molecular Dysfunction]
   861   C1511760:Deletion [Genetic Function]
   861   C1880274:Deletion [Activity]

Phrase: ":"

Phrase: "polymerase chain reaction analysis of loss of heterozygosity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   812   C1881449:Loss of Heterozygosity Analysis [Molecular Biology Research Technique]
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0337112:Chain [Manufactured Object]
   744   C0443286:Reaction [Functional Concept]
   744   C0936012:Analysis [Research Activity]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524024:analysis [Functional Concept]
   744   C1524075:Chain [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mini-repeat sequences on highly purified cell fractions."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   744   C0162326:Sequences [Nucleotide Sequence]
   744   C0205341:Repeat [Functional Concept]
   744   C1547730:Repeat [Temporal Concept]
   744   C1705914:Repeat [Conceptual Entity]
   711 E C0004793:Sequence [Nucleotide Sequence]
   711 E C0162327:Sequence [Nucleotide Sequence]
   711 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.335: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.336: 1993;81:1849[Abstract]. 

Phrase: "1993"

Phrase: ";81"

Phrase: ":"

Phrase: "1849"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.337: 26. 

Phrase: "26."
Processing 00000000.tx.338: Hainaut P, Hernandez T, Robinson A, et al. 

Phrase: "Hainaut P,"

Phrase: "Hernandez T,"

Phrase: "Robinson A,"

Phrase: "et al."
Processing 00000000.tx.339: IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. 

Phrase: "IARC Database of p53 gene mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0242356:Database [Intellectual Product]
   753   C0993637:Data Base [Intellectual Product]

Phrase: "in human tumors"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0027651:Tumors [Neoplastic Process]
   827 E C1578706:Tumor [Intellectual Product]
   827 E C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0007600:Cell lines [Cell]
   861   C0007634:Cell [Cell]
   861   C0205132:lines [Spatial Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "updated compilation,"

Phrase: "revised formats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1301627:formats [Intellectual Product]

Phrase: "and"

Phrase: "new visualisation tools."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0336791:Tool [Manufactured Object]
   793   C2827396:Tool [Manufactured Object]
Processing 00000000.tx.340: Nucleic Acids Res. 

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.341: 1998;26:205[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";26"

Phrase: ":"

Phrase: "205"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.342: 27. 

Phrase: "27."
Processing 00000000.tx.343: Misawa S, Horiike S. 

Phrase: "Misawa S,"

Phrase: "Horiike S."
Processing 00000000.tx.344: TP53 mutations in myelodysplastic syndrome. 

Phrase: "TP53 mutations in myelodysplastic syndrome."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.345: Leuk Lymphoma. 

Phrase: "Leuk Lymphoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024299:Lymphoma [Neoplastic Process]
Processing 00000000.tx.346: 1996;23:417[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1996"

Phrase: ";23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "417"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.347: 28. 

Phrase: "28."
Processing 00000000.tx.348: Mandla SG, Goobie S, Kumar RT, et al. 

Phrase: "Mandla SG,"

Phrase: "Goobie S,"

Phrase: "Kumar RT,"

Phrase: "et al."
Processing 00000000.tx.349: Genetic analysis of familial myelodysplastic syndrome: absence of linkage to chromosomes 5q31 and 7q22. 

Phrase: "Genetic analysis of familial myelodysplastic syndrome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0679560:genetic analysis [Laboratory Procedure]
   790   C0796344:Genetic Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "absence of linkage"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "to chromosomes 5q31"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0796362:chromosome 5q31 [Cell Component]
           5q31

Phrase: "and"

Phrase: "7q22."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1521647:7q22 [Cell Component]
Processing 00000000.tx.350: Cancer Genet Cytogenet. 

Phrase: "Cancer Genet Cytogenet."
Processing 00000000.tx.351: 1998;105:113[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";105"

Phrase: ":"

Phrase: "113"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.352: 29. 

Phrase: "29."
Processing 00000000.tx.353: Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. 

Phrase: "Gryfe R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Swallow C,"

Phrase: "Bapat B,"

Phrase: "Redston M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Gallinger S,"

Phrase: "Couture J."
Processing 00000000.tx.354: Molecular biology of colorectal cancer. 

Phrase: "Molecular biology of colorectal cancer."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1516164:Biology of Cancer [Biomedical Occupation or Discipline]
           Cancer Biology
   806   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   760   C0005532:Biology [Biomedical Occupation or Discipline]
   760   C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.355: Curr Prob Cancer. 

Phrase: "Curr Prob Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.356: 1997;21:233[Medline] [OrderarticleviaInfotrieve].  

Phrase: "1997"

Phrase: ";21"

Phrase: ":"

Phrase: "233"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.357: 2000 by The American Society of Hematology.

Phrase: "2000 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]

